Effects of a low glycemic load diet on body weight loss in ...

12
464 ABSTRACT Purpose: This study compared the e๏ฌ€ects of a high glycemic load (high GL) diet and low glycemic load (low GL) diet on the body weight, body fat, blood pressure, and blood lipid indicators. Methods: Twenty-one young adults aged between 21 and 28 years who were overweighted or obese (body mass index [BMI] between 23 and 33.5 kg/m 2 ) before the study and a๏ฌ…er calorie reduction diets with either low GL or high GL for 2 weeks each were examined. The study was a randomized crossover design with a 2-week washout period between the 2 types of diet. The order of the low GL and high GL diet periods was randomized. The body weight, body fat, blood pressure, levels of blood lipids, fasting glucose, insulin, homeostatic model assessment (HOMA) insulin, C-peptide, and HOMA C-peptide were measured at the baseline, as well as 2, 4, and 6 weeks a๏ฌ…er starting the experiment. Results: When subjects were on the low GL diet, they lost more weight than those eating the high GL diet (mean ยฑ SD, โˆ’2.77 ยฑ 1.09 vs. โˆ’1.56 ยฑ 0.78 kg; p < 0.001); there were greater decreases in body fat mass (โˆ’1.62 ยฑ 1.19 vs. โˆ’0.88 ยฑ 0.91 kg; p = 0.024) and BMI (โˆ’0.95 ยฑ 0.32 vs. โˆ’0.56 ยฑ 1.08 kg/m 2 ; p < 0.001). On the other hand, there were no signi๏ฌcant di๏ฌ€erences in changes in biochemical parameters, such as blood lipids and fasting glucose levels, and blood pressure. The body weight, body fat mass, BMI, percent body fat, blood pressure, cholesterol (total, low-density lipoprotein, and high-density lipoprotein), fasting glucose, C-peptide, HOMA-insulin resistance-C-peptide levels were decreased signi๏ฌcantly at 6 weeks. Conclusion: The low GL diet may be more e๏ฌ€ective in losing body weight, body fat mass, and BMI than the high GL diet for 2 weeks in healthy young overweight or obese adults. Keywords: glycemic load, obesity, weight loss, body mass index, young adult J Nutr Health. 2020 Oct;53(5):464-475 https://doi.org/10.4163/jnh.2020.53.5.464 eISSN 2288-3959 Research Article E๏ฌ€ects of a low glycemic load diet on body weight loss in overweight or obese young adults Mi Hyeon Park 1 , Kisun Nam 2 , and Sang-Jin Chung 1 1 Department of Foods and Nutrition, Kookmin University, Seoul 02707, Korea 2 Corporate Technology O๏ฌƒce, Pulmuone Co., Ltd. Seoul 06367, Korea ์‹๋‹จ์˜ ๋‹น๋ถ€ํ•˜๋Ÿ‰์— ๋”ฐ๋ฅธ 20๋Œ€ ์„ฑ์ธ์˜ ์ฒด์ค‘ ๊ฐ๋Ÿ‰ ํšจ๊ณผ ์—ฐ๊ตฌ ๋ฐ•๋ฏธํ˜„ 1 , ๋‚จ๊ธฐ์„  2 , ์ •์ƒ์ง„ 1 1 ๊ตญ๋ฏผ๋Œ€ํ•™๊ต ์‹ํ’ˆ์˜์–‘ํ•™๊ณผ 2 (์ฃผ)ํ’€๋ฌด์›, ํ’€๋ฌด์›๊ธฐ์ˆ ์› Received: Jun 12, 2020 Revised: Jul 31, 2020 Accepted: Aug 11, 2020 Correspondence to Sang-Jin Chung Department of Foods and Nutrition, Kookmin University, 77 Jeongneung-ro, Seongbuk-gu, Seoul 02707, Korea. Tel: +82-2-910-4777 E-mail: [email protected] ยฉ 2020 The Korean Nutrition Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ORCID iDs Mi Hyeon Park https://orcid.org/0000-0002-7710-0240 Kisun Nam https://orcid.org/0000-0002-6508-6007 Sang-Jin Chung https://orcid.org/0000-0003-4804-7206 Funding This research was supported by a grant from Pulmuone Co. Con๏ฌ‚ict of Interest There are no ๏ฌnancial or other issues that might lead to con๏ฌ‚ict of interest. https://e-jnh.org

Transcript of Effects of a low glycemic load diet on body weight loss in ...

464

ABSTRACTPurpose: This study compared the effects of a high glycemic load (high GL) diet and low glycemic load (low GL) diet on the body weight, body fat, blood pressure, and blood lipid indicators.Methods: Twenty-one young adults aged between 21 and 28 years who were overweighted or obese (body mass index [BMI] between 23 and 33.5 kg/m2) before the study and after calorie reduction diets with either low GL or high GL for 2 weeks each were examined. The study was a randomized crossover design with a 2-week washout period between the 2 types of diet. The order of the low GL and high GL diet periods was randomized. The body weight, body fat, blood pressure, levels of blood lipids, fasting glucose, insulin, homeostatic model assessment (HOMA) insulin, C-peptide, and HOMA C-peptide were measured at the baseline, as well as 2, 4, and 6 weeks after starting the experiment.Results: When subjects were on the low GL diet, they lost more weight than those eating the high GL diet (mean ยฑ SD, โˆ’2.77 ยฑ 1.09 vs. โˆ’1.56 ยฑ 0.78 kg; p < 0.001); there were greater decreases in body fat mass (โˆ’1.62 ยฑ 1.19 vs. โˆ’0.88 ยฑ 0.91 kg; p = 0.024) and BMI (โˆ’0.95 ยฑ 0.32 vs. โˆ’0.56 ยฑ 1.08 kg/m2; p < 0.001). On the other hand, there were no significant differences in changes in biochemical parameters, such as blood lipids and fasting glucose levels, and blood pressure. The body weight, body fat mass, BMI, percent body fat, blood pressure, cholesterol (total, low-density lipoprotein, and high-density lipoprotein), fasting glucose, C-peptide, HOMA-insulin resistance-C-peptide levels were decreased significantly at 6 weeks.Conclusion: The low GL diet may be more effective in losing body weight, body fat mass, and BMI than the high GL diet for 2 weeks in healthy young overweight or obese adults.

Keywords: glycemic load, obesity, weight loss, body mass index, young adult

J Nutr Health. 2020 Oct;53(5):464-475https://doi.org/10.4163/jnh.2020.53.5.464eISSN 2288-3959

Research Article

Effects of a low glycemic load diet on body weight loss in overweight or obese young adults Mi Hyeon Park 1, Kisun Nam 2, and Sang-Jin Chung 1

1Department of Foods and Nutrition, Kookmin University, Seoul 02707, Korea2Corporate Technology Office, Pulmuone Co., Ltd. Seoul 06367, Korea

์‹๋‹จ์˜ ๋‹น๋ถ€ํ•˜๋Ÿ‰์— ๋”ฐ๋ฅธ 20๋Œ€ ์„ฑ์ธ์˜ ์ฒด์ค‘ ๊ฐ๋Ÿ‰ ํšจ๊ณผ ์—ฐ๊ตฌ๋ฐ•๋ฏธํ˜„ 1, ๋‚จ๊ธฐ์„  2, ์ •์ƒ์ง„ 1

1๊ตญ๋ฏผ๋Œ€ํ•™๊ต ์‹ํ’ˆ์˜์–‘ํ•™๊ณผ2(์ฃผ)ํ’€๋ฌด์›, ํ’€๋ฌด์›๊ธฐ์ˆ ์›

Received: Jun 12, 2020Revised: Jul 31, 2020Accepted: Aug 11, 2020

Correspondence toSang-Jin ChungDepartment of Foods and Nutrition, Kookmin University, 77 Jeongneung-ro, Seongbuk-gu, Seoul 02707, Korea. Tel: +82-2-910-4777E-mail: [email protected]

ยฉ 2020 The Korean Nutrition SocietyThis is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

ORCID iDsMi Hyeon Park https://orcid.org/0000-0002-7710-0240Kisun Nam https://orcid.org/0000-0002-6508-6007Sang-Jin Chung https://orcid.org/0000-0003-4804-7206

FundingThis research was supported by a grant from Pulmuone Co.

Conflict of InterestThere are no financial or other issues that might lead to conflict of interest.

https://e-jnh.org

์„œ๋ก 

๋น„๋งŒ ์œ ๋ณ‘๋ฅ  ์ฆ๊ฐ€์™€ ํ•จ๊ป˜ ๋น„๋งŒ๊ณผ ๊ด€๋ จ๋œ ์งˆ๋ณ‘์€ ๊ตญ์ œ์ ์œผ๋กœ ์ค‘์š”ํ•œ ๋ฌธ์ œ ์ค‘ ํ•˜๋‚˜๋กœ ์—ฌ๊ฒจ์ง€๊ณ 

์žˆ๋‹ค [1]. ์šฐ๋ฆฌ๋‚˜๋ผ๋Š” ๋น ๋ฅธ ์‚ฌํšŒ ๊ฒฝ์ œ์ ์ธ ์„ฑ์žฅ๊ณผ ํ•จ๊ป˜ ์ƒํ™œ ์Šต๊ด€์ด ๋ณ€ํ•˜๋ฉด์„œ ๋น„๋งŒ์ด ๋ˆˆ์— ๋„๊ฒŒ ์ฆ๊ฐ€ํ•˜๊ณ  ์žˆ๋‹ค. ๊ตญ๋ฏผ๊ฑด๊ฐ•์˜์–‘์กฐ์‚ฌ์˜ ๋น„๋งŒ ์œ ๋ณ‘๋ฅ  ์ถ”์ด๋ฅผ ๋ณด๋ฉด ์„ฑ์ธ ์—ฌ์„ฑ์€ 1998๋…„ 26.2%

์—์„œ 2003๋…„ 25.1%๋กœ ๋ณ€ํ™”๊ฐ€ ๊ฑฐ์˜ ์—†์ง€๋งŒ, ๋‚จ์„ฑ์€ 25.1%์—์„œ 37.6%๋กœ ํฌ๊ฒŒ ์ฆ๊ฐ€ํ•˜๊ณ  ์žˆ๋Š” ๊ฒƒ์„ ๋ณผ ์ˆ˜ ์žˆ๋‹ค [2,3]. ๋น„๋งŒ์€ ๊ณผ๋‹คํ•œ ์—ด๋Ÿ‰์„ญ์ทจ์™€ ํ™œ๋™๋Ÿ‰์˜ ๊ฐ์†Œ์— ๊ธฐ์ธ๋˜๋Š” ๊ฒƒ์œผ๋กœ, ์„œ๊ตฌ์—์„œ๋Š” ์—ด๋Ÿ‰์— ๊ธฐ์—ฌํ•˜๋Š” ์˜์–‘์†Œ ์ค‘ ํŠนํžˆ ์ง€๋ฐฉ ์„ญ์ทจ๊ฐ€ ๋น„๋งŒ๊ณผ ๊ด€๋ จ์„ฑ์ด ๋†’์€ ๊ฒƒ์œผ๋กœ ์•Œ๋ ค์ ธ ์™”๋‹ค.

๊ทธ๋Ÿฌ๋‚˜ ์ง€๋‚œ 20๋…„ ๋™์•ˆ ์ผ๋ถ€์˜ ์„ ์ง„๊ตญ์—์„œ ์ง€๋ฐฉ ์„ญ์ทจ์— ์˜ํ•œ ์—๋„ˆ์ง€ ์„ญ์ทจ๋น„์œจ์ด ๊ฐ์†Œํ•จ์—๋„

๋ถˆ๊ตฌํ•˜๊ณ  ๋น„๋งŒ ๋ฐœ๋ณ‘๋ฅ ์ด ์ฆ๊ฐ€ํ•˜๊ณ  ์žˆ์–ด ์„ญ์ทจํ•˜๋Š” ์ง€๋ฐฉ๋ณด๋‹ค ์ตœ๊ทผ ์ฆ๊ฐ€ํ•˜๊ณ  ์žˆ๋Š” ๋‹น ์„ญ์ทจ๋Ÿ‰

๋“ฑ ํƒ„์ˆ˜ํ™”๋ฌผ์ด ์ฒด์ค‘ ์ฆ๊ฐ€์˜ ์ฃผ์š” ์›์ธ์œผ๋กœ ์ฃผ๋ชฉ๋ฐ›๊ธฐ ์‹œ์ž‘ํ–ˆ๋‹ค [1]. ์ด์™€ ํ•จ๊ป˜ ์ตœ๊ทผ ๊ณ ํƒ„์ˆ˜ํ™”๋ฌผ ์‹์‚ฌ์— ์˜ํ•œ ๋‹น๋‡จ๋ณ‘, ์‹ฌํ˜ˆ๊ด€ ์งˆํ™˜, ๋น„๋งŒ ๋“ฑ ์ƒํ™œ์Šต๊ด€๋ณ‘์˜ ์œ„ํ—˜๊ณผ ๊ด€๋ จ๋œ ์—ฐ๊ตฌ ๊ฒฐ๊ณผ๊ฐ€ ๋ณด๊ณ ๋˜๊ณ  ์žˆ๊ณ  ์ „ ์„ธ๊ณ„์ ์œผ๋กœ ์ด๋กœ ์ธํ•œ ์‚ฌ๋ง๋ฅ ์ด ๋”์šฑ ์ฆ๊ฐ€ํ•  ๊ฒƒ์œผ๋กœ ์˜ˆ์ƒ๋˜๊ณ  ์žˆ๋‹ค. ์ด์™€ ๊ด€๋ จํ•˜์—ฌ ์‹์‚ฌ์—์„œ์˜ ํƒ„์ˆ˜ํ™”๋ฌผ์˜ ์—ญํ• , ์ฆ‰ ํ˜ˆ๋‹น์ง€์ˆ˜ (glycemic index), ๋‹น๋ถ€ํ•˜์ง€์ˆ˜ (glycemic load,

GL)์— ๋Œ€ํ•œ ๋” ๋งŽ์€ ์—ฐ๊ตฌ๊ฐ€ ํ•„์š”ํ•˜๋‹ค [4,5].

ํƒ„์ˆ˜ํ™”๋ฌผ์€ ์–‘์  ์„ญ์ทจ๋ฟ ์•„๋‹ˆ๋ผ ์งˆ์  ์„ญ์ทจ๋„ ์ค‘์š”ํ•œ ๋ฐ ์ด๋ฅผ ํ‰๊ฐ€ํ•˜๊ธฐ ์œ„ํ•ด์„œ ํ˜ˆ๋‹น์ง€์ˆ˜๋ฅผ ์ง€ํ‘œ๋กœ ๋งŽ์ด ์‚ฌ์šฉํ•˜๊ณ  ์žˆ๋‹ค. ํ˜ˆ๋‹น์ง€์ˆ˜๋ž€ ํฌ๋„๋‹น ๋˜๋Š” ํฐ ๋นต ๋“ฑ์˜ ๊ธฐ์ค€์ด ๋˜๋Š” ์‹ํ’ˆ๊ณผ ๋™๋Ÿ‰์˜ ํƒ„์ˆ˜ํ™”๋ฌผ์„ ํ•จ์œ ํ•œ ํŠน์ •์‹ํ’ˆ์˜ ํ˜ˆ๋‹น ๋ฐ˜์‘ ์ •๋„๋ฅผ ๊ธฐ์ค€์ด ๋˜๋Š” ์‹ํ’ˆ์˜ ํ˜ˆ๋‹น ๋ฐ˜์‘ ์ •๋„์™€ ๋น„๊ตํ•œ

๊ฐ’์ด๋‹ค[4,6,7]. ์‹ํ›„ ํ˜ˆ๋‹น ๋ฐ˜์‘์€ ์Œ์‹์˜ ํ˜ˆ๋‹น์ง€์ˆ˜๋ฟ๋งŒ ์•„๋‹ˆ๋ผ ์„ญ์ทจํ•œ ํƒ„์ˆ˜ํ™”๋ฌผ ์–‘์˜ ์˜ํ–ฅ์„

๋ฐ›์œผ๋ฏ€๋กœ ์ด์— ์„ญ์ทจํ•œ ํƒ„์ˆ˜ํ™”๋ฌผ์˜ ์–‘์„ ๊ณ ๋ คํ•œ ๋‹น๋ถ€ํ•˜์ง€์ˆ˜๊ฐ€ ๊ฐœ๋ฐœ๋˜์–ด ์‚ฌ์šฉ๋˜๊ณ  ์žˆ๋‹ค [7].

๋‹น๋ถ€ํ•˜์ง€์ˆ˜๋Š” ์‹ํ’ˆ์˜ ํ˜ˆ๋‹น์ง€์ˆ˜์™€ ์„ญ์ทจํ•˜๋Š” ํƒ„์ˆ˜ํ™”๋ฌผ ํ•จ๋Ÿ‰์„ ๋ฐ˜์˜ํ•˜์—ฌ ์ •์˜ํ•˜๋Š” ๊ฐ’์ด๋‹ค [8].

๋Œ€์‚ฌ์„ฑ ์งˆํ™˜๊ณผ ํ˜ˆ๋‹น ์ง€์ˆ˜์™€ ๊ด€๋ จ๋œ ์„ ํ–‰ ์—ฐ๊ตฌ์—์„œ Du ๋“ฑ [9]์€ ๊ฐ์ž์™€ ์‹œ๋ฆฌ์–ผ๋ณด๋‹ค ์ฃผ๋กœ ๊ณผ์ผ๊ณผ ์œ ์ œํ’ˆ์œผ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ํ˜ˆ๋‹น์ง€์ˆ˜๊ฐ€ ๋‚ฎ์€ ์‹์‚ฌ๋Š” ์ธ์Š๋ฆฐ ๋ฏผ๊ฐ์„ฑ๊ณผ ์ง€์งˆ ๋Œ€์‚ฌ๋ฅผ ๊ฐœ์„ ์‹œ์ผฐ๊ณ ,

๋งŒ์„ฑ ์—ผ์ฆ์„ ์ค„์˜€๋‹ค๊ณ  ๋ณด๊ณ ํ•˜์˜€๋‹ค. Riccardi ๋“ฑ [7]์˜ ์—ฐ๊ตฌ์—์„œ๋Š” ๋‚ฎ์€ ํ˜ˆ๋‹น์ง€์ˆ˜ ๋˜๋Š” ์‹์ด์„ฌ์œ ์†Œ๋ฅผ ๋งŽ์ด ํ•จ์œ ํ•œ ์‹์‚ฌ๋ฅผ ์„ญ์ทจํ•œ ๊ฒฐ๊ณผ ๋‹น๋‡จ๋ณ‘ ์œ„ํ—˜์ด ๊ฐ์†Œํ•˜์˜€์„ ๋ฟ๋งŒ ์•„๋‹ˆ๋ผ ๊ด€์ƒ๋™๋งฅ์„ฑ

์‹ฌ์žฅ๋ณ‘ (coronary heart disease) ์œ„ํ—˜์ด ์ค„์—ˆ๋‹ค๊ณ  ๋ณด๊ณ ํ•˜์˜€๋‹ค. ๋†’์€ ํ˜ˆ๋‹น์ง€์ˆ˜, ๋‹น๋ถ€ํ•˜์ง€์ˆ˜ ์‹์‚ฌ์™€ ๋น„๋งŒ๊ณผ์˜ ๊ด€๋ จ์„ฑ์„ ์‚ดํŽด๋ณธ Ma ๋“ฑ [1]์˜ ์„ ํ–‰์—ฐ๊ตฌ์—์„œ๋Š” ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜ (body mass index,

BMI)์˜ ์˜ˆ์ธก์ธ์ž๋กœ ์‹์ด์˜ ํ˜ˆ๋‹น์ง€์ˆ˜๊ฐ€ ๊ฐ•๋ ฅํ•˜๊ฒŒ ์˜ํ–ฅ์„ ๋ฏธ์น˜๋Š” ์š”์ธ์œผ๋กœ ๋ณด๊ณ ํ•˜์˜€๊ณ , Lau

๋“ฑ [10]์˜ ์—ฐ๊ตฌ์—์„œ๋Š” ์‹์ด ํ˜ˆ๋‹น์ง€์ˆ˜์™€ ๋‹น๋ถ€ํ•˜์ง€์ˆ˜๋Š” ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜์™€ ์–‘์˜ ๊ด€๋ จ์„ฑ์ด ์žˆ๋‹ค๊ณ 

๋ฐœํ‘œํ•˜์˜€๋‹ค. ํ˜ˆ๋‹น์ง€์ˆ˜๊ฐ€ ์ฒด์ค‘์— ์˜ํ–ฅ์„ ๋ฏธ์น˜๋Š” ์ƒ๋ฆฌํ•™์  ๊ธฐ์ „์„ ์‚ดํŽด๋ณด๋ฉด ํ˜ˆ๋‹น์ง€์ˆ˜๊ฐ€ ๋†’์€

์‹ํ’ˆ์„ ์„ญ์ทจํ•˜๋ฉด ์ดˆ๊ธฐ๋‹จ๊ณ„์—์„œ ํ˜ˆ๋‹น์„ ๋น ๋ฅด๊ฒŒ ์ฆ๊ฐ€์‹œํ‚ค๊ณ , ๊ทธ ๊ฒฐ๊ณผ ์ธ์Š๋ฆฐ ๋ถ„๋น„ ์ฆ๊ฐ€์™€ ์ง€๋ฐฉ์˜ ์‚ฐํ™”๊ฐ€ ์–ต์ œ๋œ๋‹ค. ๊ทธ ๋‹ค์Œ ๋‹จ๊ณ„๋กœ ํ˜ˆ๋‹น์ด ๊ฐ์†Œ๋˜๋‚˜ ์ง€๋ฐฉ ์‚ฐํ™”๋Š” ์—ฌ์ „ํžˆ ์–ต์ œ๋˜๊ณ , ๋งˆ์ง€๋ง‰

๋‹จ๊ณ„์—์„œ ํฌ๋„๋‹น ํ•ฉ์„ฑ ๋ฐ ์ง€๋ฐฉ ์‚ฐํ™”๋ฅผ ์ž๊ทนํ•˜์—ฌ ํ˜ˆ๋‹น ์กฐ์ ˆ์— ๊ด€๋ จ๋œ ํ˜ธ๋ฅด๋ชฌ๊ณผ ๋Œ€์‚ฌ์  ๋ณ€ํ™”๋ฅผ ์œ ๋„ํ•จ์œผ๋กœ์จ ์ฒด์ง€๋ฐฉ์„ ์ฆ๊ฐ€์‹œํ‚จ๋‹ค๋Š” ๊ฒƒ์ด๋‹ค [11,12]. ์ „์„ธ๊ณ„์ ์œผ๋กœ ๋น„๋งŒ๊ณผ ๋†’์€ ํ˜ˆ๋‹น์ง€์ˆ˜, ๋‹น๋ถ€ํ•˜์ง€์ˆ˜ ์‹์‚ฌ์˜ ๊ด€๋ จ์„ฑ์— ๋Œ€ํ•œ ๋‹ค์–‘ํ•œ ์—ฐ๊ตฌ๊ฐ€ ์ง„ํ–‰๋˜์—ˆ์œผ๋‚˜ ์šฐ๋ฆฌ๋‚˜๋ผ๋Š” ํƒ„์ˆ˜ํ™”๋ฌผ ์œ„์ฃผ์˜ ์‹์ƒํ™œ์—๋„ ๋ถˆ๊ตฌํ•˜๊ณ  ์šฐ๋ฆฌ๋‚˜๋ผ ์‹์‚ฌ์˜ ํ˜ˆ๋‹น์ง€์ˆ˜ ๊ด€๋ จ ์—ฐ๊ตฌ๋Š” ๊ทนํžˆ ๋“œ๋ฌธ ์‹ค์ •์ด๋‹ค [4].

์ด์— ๋ณธ ์—ฐ๊ตฌ๋Š” ์šฐ๋ฆฌ๋‚˜๋ผ ๊ณผ์ฒด์ค‘ ๋˜๋Š” ๋น„๋งŒ ๋Œ€์ƒ์ž์—๊ฒŒ ์ฒด์ค‘ ๊ฐ๋Ÿ‰์„ ์œ„ํ•ด ์—ด๋Ÿ‰์„ ์ค„์ด๋˜ ํ‰์†Œ

์„ญ์ทจํ•˜๋Š” ์ˆ˜์ค€์˜ ํƒ„์ˆ˜ํ™”๋ฌผ ์–‘๊ณผ ํ˜ˆ๋‹น๋ถ€ํ•˜๋ฅผ ์ฃผ๋Š” ์‹์‚ฌ์™€ ์ด๋ฅผ ๋‚ฎ๊ฒŒ ์„ค๊ณ„ํ•œ ์‹์‚ฌ๋ฅผ ์„ญ์ทจํ•˜๊ฒŒ

ํ•œ ํ›„ ์ฒด์ค‘, ํ—ˆ๋ฆฌ๋‘˜๋ ˆ, ์ฒด์ง€๋ฐฉ, ํ˜ˆ์•• ๋“ฑ์˜ ๋น„๋งŒ ๊ด€๋ จ ์œ„ํ—˜ ์ง€ํ‘œ์˜ ๋ณ€ํ™”๋ฅผ ์•Œ์•„๋ณด๊ณ ์ž ํ•˜์˜€๋‹ค.

465https://doi.org/10.4163/jnh.2020.53.5.464

๋‹น๋ถ€ํ•˜๋Ÿ‰์— ๋”ฐ๋ฅธ ์ฒด์ค‘ ๊ฐ๋Ÿ‰ ํšจ๊ณผ ์—ฐ๊ตฌ

https://e-jnh.org

์—ฐ๊ตฌ๋ฐฉ๋ฒ•

์—ฐ๊ตฌ๋Œ€์ƒ ๋ฐ ๊ธฐ๊ฐ„๋ณธ ์—ฐ๊ตฌ๋Š” 2015๋…„ 7์›”๋ถ€ํ„ฐ 8์›”๊นŒ์ง€ ์ด 42์ผ (6์ฃผ) ๋™์•ˆ ์ง„ํ–‰๋˜์—ˆ๋‹ค. K๋Œ€ํ•™๊ต ๋‚ด์˜ ๊ฐ ๊ฑด๋ฌผ ๊ฒŒ์‹œํŒ ๋ฐ SNS์˜ ๋ชจ์ง‘๊ณต๊ณ ๋ฅผ ํ†ตํ•˜์—ฌ ์ฒด์ค‘ ๊ฐ๋Ÿ‰์— ๊ด€์‹ฌ์ด ์žˆ๋Š” ๊ณผ์ฒด์ค‘ ๋˜๋Š” ๋น„๋งŒ (BMI โ‰ฅ23 kg/m2)

์ธ 20๋Œ€ ์„ฑ์ธ์„ ๋Œ€์ƒ์œผ๋กœ ๋Œ€์ƒ์ž๋ฅผ ๋ชจ์ง‘ํ•˜์˜€๋‹ค.

๋Œ€์ƒ์ž๋Š” ๋ณธ ์—ฐ๊ตฌ์— ์ฐธ์—ฌํ•˜๊ธฐ ์ „ ์‹คํ—˜์‹ค์— ๋ฐฉ๋ฌธํ•˜์—ฌ ๋‹ด๋‹น ์—ฐ๊ตฌ์›์—๊ฒŒ ์—ฐ๊ตฌ์˜ ์ „๋ฐ˜์ ์ธ ๊ฐœ์š”์— ๋Œ€ํ•ด ์„ค๋ช…์„ ๋“ค์€ ํ›„, ์ž๋ฐœ์ ์œผ๋กœ ์—ฐ๊ตฌ ์ฐธ์—ฌ์— ๋™์˜ํ•˜์˜€๋‹ค. ๋Œ€์ƒ์ž์˜ ๊ณผ์ฒด์ค‘ ๋˜๋Š” ๋น„๋งŒ

์—ฌ๋ถ€๋ฅผ ์•Œ๊ธฐ ์œ„ํ•ด ์ฒด์„ฑ๋ถ„ ๋ถ„์„ (Inbody720; Biospace Co., Seoul, Korea)์„ ํ•˜์˜€๊ณ , ๊ธฐ์ดˆ ์ •๋ณด

๋ฐ ํ˜„์žฌ ์•ฝ๋ฌผ ๋ณต์šฉ์—ฌ๋ถ€, ์‹ํ’ˆ ์•Œ๋ ˆ๋ฅด๊ธฐ ์—ฌ๋ถ€, ๊ทธ ๋ฐ–์— ๊ธฐํƒ€์‚ฌํ•ญ ๋“ฑ์ด ํฌํ•จ๋˜์–ด ์žˆ๋Š” ์‚ฌ์ „์กฐ์‚ฌ๋ฅผ ์‹ค์‹œํ•˜์˜€๋‹ค. ์ด๋ฅผ ์ข…ํ•ฉํ•˜์—ฌ ์—ฐ๊ตฌ์— ์ ์ ˆํ•˜๋‹ค๊ณ  ํŒ๋‹จ๋œ ์ž์— ํ•œ์—์„œ ์—ฐ๊ตฌ์— ์ฐธ์—ฌํ•˜์˜€๋‹ค.

๋Œ€์ƒ์ž๋Š” ์ด 31๋ช…์ด ์ง€์›ํ•˜์˜€์œผ๋‚˜ 9๋ช…์€ ์—ฐ๊ตฌ ์ฐธ์—ฌ ์กฐ๊ฑด์— ์ถฉ์กฑํ•˜์ง€ ์•Š์•„ ์ตœ์ข…์ ์œผ๋กœ 22๋ช…์ด ์—ฐ๊ตฌ์— ์ฐธ์—ฌํ•˜์˜€๋‹ค. ์—ฌ์„ฑ 1๋ช…์ด ์ค‘๋„ ํƒˆ๋ฝํ•˜์—ฌ ๋‚จ์„ฑ 10๋ช…, ์—ฌ์„ฑ 11๋ช…์œผ๋กœ ์ด 21๋ช…์„ ๋Œ€์ƒ์œผ๋กœ ์—ฐ๊ตฌ๋ฅผ ์™„๋ฃŒํ•˜์˜€๋‹ค. ๋ณธ ์—ฐ๊ตฌ๋Š” ๊ตญ๋ฏผ๋Œ€ํ•™๊ต ์ƒ๋ช…์œค๋ฆฌ์‹ฌ์˜์œ„์›ํšŒ์˜ ์Šน์ธ (์Šน์ธ๋ฒˆํ˜ธ: KMU-

201504-HR-055-R2-C1)์„ ๋ฐ›์•„ ์ง„ํ–‰๋˜์—ˆ๋‹ค.

์—ฐ๊ตฌ๋ฐฉ๋ฒ• ๋ฐ ๋‚ด์šฉ๋ชจ๋“  ๋Œ€์ƒ์ž๋Š” ์ฒด์ค‘ ๊ฐ๋Ÿ‰์„ ๋ชฉ์ ์œผ๋กœ ํ•˜๋ฃจ ํ•„์š” ์—ด๋Ÿ‰์˜ ์•ฝ 70%๋ฅผ ์ œ๊ณต๋ฐ›๋„๋ก ์กฐ์ • ์ฒด์ค‘์„

๊ธฐ์ค€์œผ๋กœ ๊ฐ€๋ฒผ์šด ํ™œ๋™์„ ์œ„ํ•œ ์—๋„ˆ์ง€ ์š”๊ตฌ๋Ÿ‰์ธ 25 kcal/kg์„ ๊ณฑํ•˜์—ฌ ํ•˜๋ฃจ ํ•„์š” ์—ด๋Ÿ‰์„ ๊ณ„์‚ฐํ•˜์˜€๋‹ค [13].

ํ•˜๋ฃจ ํ•„์š” ์—ด๋Ÿ‰ (kcal) = ์กฐ์ • ์ฒด์ค‘ (ํ‘œ์ค€ ์ฒด์ค‘ + (ํ˜„์žฌ ์ฒด์ค‘ โˆ’ ํ‘œ์ค€ ์ฒด์ค‘) ร— 0.25) ร— 25 kcal

๊ทธ ํ›„ ๊ณ„์‚ฐ๋œ ๊ฐ ๊ฐœ์ธ์˜ ํ•„์š” ์—ด๋Ÿ‰์„ ๊ณ ๋ คํ•˜์—ฌ ์‹์‚ฌ๋ฅผ ๊ตฌ์„ฑํ•˜์—ฌ 1,200 kcal (์—ฌ์ž: 5๋ช…), 1,500

kcal (๋‚จ์ž: 5๋ช…, ์—ฌ์ž: 6๋ช…), 1,800 kcal (๋‚จ์ž: 5๋ช…)์˜ ์„ธ ์ข…๋ฅ˜๋กœ ๋ณธ์ธ์— ๊ฐ€๊นŒ์šด ์—ด๋Ÿ‰์œผ๋กœ ์ œ๊ณตํ•˜์˜€๋‹ค.

์‹คํ—˜์€ cross-over ๋””์ž์ธ์œผ๋กœ 6์ฃผ๊ฐ„ ์ง„ํ–‰๋˜์—ˆ๋‹ค. ๋‚จ๋…€ ์„ฑ๋น„๋ฅผ ๊ณ ๋ คํ•˜์—ฌ ๋Œ€์ƒ์ž๋ฅผ ๋ฌด์ž‘์œ„๋กœ

๋‘ ๊ทธ๋ฃน์œผ๋กœ ๋‚˜๋ˆ„์–ด ์ค‘๊ฐ„ wash-out 2์ฃผ๋ฅผ ์ œ์™ธํ•˜๊ณ  ์ „๋ฐ˜๋ถ€ 2์ฃผ, ํ›„๋ฐ˜๋ถ€ 2์ฃผ ๋™์•ˆ ์‹์‚ฌ๋ฅผ ์ œ๊ณตํ•˜์˜€๋‹ค. ์‹์‚ฌ๋Š” ๋Œ€์ƒ์ž๋“ค์ด ํ‰์†Œ์— ์„ญ์ทจํ•˜๋Š” ์–‘๊ณผ ์œ ์‚ฌํ•œ ์ˆ˜์ค€์˜ ๋‹น๋ถ€ํ•˜๋Ÿ‰์„ ๊ฐ€์ง„ ์‹์‚ฌ

(high GL)์™€ ๋‹น๋ถ€ํ•˜๋Ÿ‰์ด ๋‚ฎ๊ฒŒ ์„ค๊ณ„๋œ ์‹์‚ฌ (low GL)๋กœ ๊ตฌ์„ฑ๋˜์—ˆ๊ณ , ์—ด๋Ÿ‰์€ ๊ฐœ์ธ์˜ ์—ด๋Ÿ‰ ํ•„์š”๋Ÿ‰์˜ 70%๋กœ ์กฐ์ •๋˜์–ด ๋™์ผํ•œ ์—ด๋Ÿ‰์œผ๋กœ ๊ฐ ๊ฐœ์ธ์—๊ฒŒ 2์ฃผ๊ฐ„ high GL, 2์ฃผ๊ฐ„ low GL ์‹์‚ฌ๋กœ

์ œ๊ณตํ•˜์˜€๋‹ค. ์ฆ‰, ๊ทธ๋ฃน1 (10๋ช…, low โ†’ high GL ๊ทธ๋ฃน)์€ ์ฒ˜์Œ 2์ฃผ ๋™์•ˆ์€ ๋‹น๋ถ€ํ•˜๋Ÿ‰์ด ๋‚ฎ๊ฒŒ ์„ค๊ณ„๋œ low GL ์‹์‚ฌ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์ œ๊ณตํ•˜์˜€๊ณ , ๊ทธ๋ฃน2 (11๋ช…, high โ†’ low GL ๊ทธ๋ฃน)๋Š” ํ‰์†Œ์— ์„ญ์ทจํ•˜๋Š” ํƒ„์ˆ˜ํ™”๋ฌผ ์–‘๊ณผ ์œ ์‚ฌํ•œ ๋‹น๋ถ€ํ•˜๋Ÿ‰์„ ๊ฐ€์ง„ high GL ์‹์‚ฌ๋ฅผ ๋จผ์ € ์ œ๊ณตํ•˜์˜€๋‹ค. ์ค‘๊ฐ„ 2์ฃผ ๋™์•ˆ์˜ wash-out๋ฅผ ๊ฑฐ์นœ ํ›„, ๋งˆ์ง€๋ง‰ 2์ฃผ ๋™์•ˆ์€ ์ฒ˜์Œ 2์ฃผ์™€๋Š” ๋ฐ˜๋Œ€๋กœ low GL ์‹์‚ฌ๋ฅผ ํ–ˆ๋˜ ๊ทธ๋ฃน1์€

high GL ์‹์‚ฌ๋ฅผ, high GL ์‹์‚ฌ๋ฅผ ํ–ˆ๋˜ ๊ทธ๋ฃน2๋Š” low GL ์‹์‚ฌ๋ฅผ ์ œ๊ณต๋ฐ›์•˜๋‹ค. ์‹์‚ฌ์™€ ์‹คํ—˜ ๋””์ž์ธ์€ Fig. 1๊ณผ ๊ฐ™๋‹ค.

Low GL ์‹์‚ฌ์—์„œ 1,200 kcal ์‹์‚ฌ์— ๋ฐฐ์ •๋œ ๊ฒฝ์šฐ ์‹ค์ œ ์ œ๊ณต๋œ ์‹๋‹จ์˜ ์—ด๋Ÿ‰์€ 1,176.9 kcal, 1,500

kcal ์‹์‚ฌ๋Š” 1,471.5 kcal, 1,800 kcal ์‹์‚ฌ๋Š” 1,801.6 kcal์ด์—ˆ์œผ๋ฉฐ high GL ์‹์‚ฌ์—์„œ 1,200 kcal ์‹

466https://doi.org/10.4163/jnh.2020.53.5.464

๋‹น๋ถ€ํ•˜๋Ÿ‰์— ๋”ฐ๋ฅธ ์ฒด์ค‘ ๊ฐ๋Ÿ‰ ํšจ๊ณผ ์—ฐ๊ตฌ

https://e-jnh.org

์‚ฌ ๋Œ€์ƒ์ž์˜ ๊ฒฝ์šฐ ์‹ค์ œ ์ œ๊ณต๋œ ์‹๋‹จ์˜ ์—ด๋Ÿ‰์€ 1,185.0 kcal, 1,500 kcal ์‹์‚ฌ๋Š” 1,508.2 kcal, 1,800

kcal ์‹์‚ฌ๋Š” 1,807.4 kcal์ด์—ˆ๋‹ค. ๊ฐ ์‹ํ’ˆ์˜ ๋‹น๋ถ€ํ•˜๋Ÿ‰์€ ์ด์ „ ์—ฐ๊ตฌ์ธ ์‹์‚ฌ์˜ ์˜์–‘์„ฑ๋ถ„์— ์˜ํ•ด

ํ˜ˆ๋‹น๋ถ€ํ•˜๋ฅผ ์ถ”์ •ํ•˜๋Š” ์‹์„ ์ด์šฉํ•˜์—ฌ ์ œ๊ณต๋œ ์‹๋‹จ ์Œ์‹์˜ ๋‹น๋ถ€ํ•˜๋Ÿ‰์„ ๊ตฌํ•ด ์‚ฌ์šฉํ•˜์˜€๋‹ค [14].

High GL ๊ทธ๋ฃน์˜ ๋‹น๋ถ€ํ•˜๋Ÿ‰์€ low GL ๊ทธ๋ฃน์˜ ์•ฝ 2๋ฐฐ๋กœ ์„ค์ •ํ•˜์—ฌ ์‹์‚ฌ๋ฅผ ๊ตฌ์„ฑํ•˜์˜€๋‹ค. ๊ฐ ์‹์‚ฌ์˜

์ œ๊ณต์—ด๋Ÿ‰์— ๋”ฐ๋ฅธ ํ‰๊ท  ์˜์–‘์†Œ ๋น„์œจ (ํƒ„์ˆ˜ํ™”๋ฌผ, ๋‹จ๋ฐฑ์งˆ, ์ง€๋ฐฉ)์€ Table 1๊ณผ ๊ฐ™๋‹ค.

์‹คํ—˜์„ ์‹œ์ž‘ํ•˜๊ธฐ ์ „ ๋Œ€์ƒ์ž์˜ ์‹ ์žฅ, ์ฒด์ค‘, ์ฒด์ง€๋ฐฉ (Inbody720; Biospace Co.)๊ณผ ํ˜ˆ์•• (HEM-

7310; Omron, Kyoto, Japan)์„ ์ธก์ •ํ•˜์˜€๋‹ค. ์ค‘๊ฐ„ 2์ฃผ๋ฅผ ์ œ์™ธํ•œ ์‹คํ—˜ ์ฐธ์—ฌ ๊ธฐ๊ฐ„ ๋™์•ˆ ๋Œ€์ƒ์ž์˜

์‹ ์žฅ, ์ฒด์ค‘, ์ฒด์ง€๋ฐฉ๊ณผ ํ˜ˆ์••์„ ๋งค์ผ ์•„์นจ ์‹์‚ฌํ•˜๊ธฐ ์ „์— ์ธก์ •ํ•˜์˜€๊ณ , ๋˜ํ•œ ์ œ๊ณตํ•œ ์—ฐ๊ตฌ ์‹์‚ฌ ์™ธ์— ์„ญ์ทจํ•œ ๊ฒƒ์ด ์žˆ๋Š”์ง€ ๋งค์ผ ๋ฉด๋‹ดํ•˜์—ฌ ํ™•์ธํ•˜์˜€๋‹ค. ์ฑ„ํ˜ˆ์€ 9์‹œ์— ์ž„์ƒ๋ณ‘๋ฆฌ์‚ฌ๊ฐ€ ์—ฐ๊ตฌ์‹ค๋กœ ๋ฐฉ๋ฌธํ•˜์—ฌ ์‹คํ—˜ ์ „๊ณผ 2์ฃผ, 4์ฃผ, 6์ฃผ ํ›„์— ์ด 4๋ฒˆ ์‹ค์‹œํ•˜์˜€๋‹ค. ์ฑ„ํ˜ˆ์„ ํ•œ ํ˜ˆ์•ก์˜ ํ˜ˆ์ฒญ์„ ๋ถ„๋ฆฌํ•˜์—ฌ

์ค‘์„ฑ์ง€๋ฐฉ (triglyceride), ์ด์ฝœ๋ ˆ์Šคํ…Œ๋กค (total cholesterol), ๊ณ ๋ฐ€๋„์ง€์งˆ๋‹จ๋ฐฑ์งˆ (high-density li-

467https://doi.org/10.4163/jnh.2020.53.5.464

๋‹น๋ถ€ํ•˜๋Ÿ‰์— ๋”ฐ๋ฅธ ์ฒด์ค‘ ๊ฐ๋Ÿ‰ ํšจ๊ณผ ์—ฐ๊ตฌ

https://e-jnh.org

Randomly assigned (n = 22)

Group 1 Group 2

2 weeks

Assessed for eligibility (n = 31)

Lost to follow-up (n = 1)- Lost interest, withdraw (n = 1)

Excluded (n = 9)- Did not meet inclusion criteria (n = 9)

Low GL diet (n = 11) High GL diet (n = 11)

Wash-out (n = 11) Wash-out (n = 11)

High GL diet (n = 11) Low GL diet (n = 11)

Completed study (n = 10) Completed study (n = 11)

2 weeks

2 weeks

Fig. 1. Diagram of the study. GL, glycemic load.

Table 1. Composition of diets used for the studyVariables Low GL group High GL groupIntended calorie (kcal/day) 1,200 1,500 1,800 1,200 1,500 1,800Provided calorie (kcal/day) 1,176.9 1,471.5 1,801.6 1,185.0 1,508.2 1,807.4Estimated GL 65.7 82.0 94.6 142.8 180.0 214.3Percentage of calorie from

Carbohydrate 46 45 43 78 78 76Protein 35 34 37 13 12 14Fat 19 21 20 9 10 11

GL, glycemic load.

poprotein; HDL)-์ฝœ๋ ˆ์Šคํ…Œ๋กค, ์ €๋ฐ€๋„์ง€์งˆ๋‹จ๋ฐฑ์งˆ (low-density lipoprotein; LDL)-์ฝœ๋ ˆ์Šคํ…Œ๋กค,

๊ณต๋ณตํ˜ˆ๋‹น, ์ธ์Š๋ฆฐ, C-peptide๋ฅผ ์ธก์ •ํ•˜์˜€๋‹ค. Homeostasis model assessment (HOMA) calcula-

tor๋ฅผ ์ด์šฉํ•˜์—ฌ ์ธ์Š๋ฆฐ์˜ ์ €ํ•ญ์„ฑ์„ ํ‰๊ฐ€ํ•˜๊ธฐ ์œ„ํ•ด ์‚ฌ์šฉ๋˜๋Š” ์ž„์ƒ์  ์ง€ํ‘œ์ธ ์ธ์Š๋ฆฐ HOMA ์ง€์ˆ˜ (HOMA to quantify insulin resistance)์™€ C-peptide๋ฅผ ์ด์šฉํ•˜์—ฌ ๊ณ„์‚ฐํ•œ C-peptide HOMA ์ง€์ˆ˜ (HOMA to quantify insulin resistance C-peptide)์˜ ๊ฐ’์„ ์‚ฐ์ถœํ•˜์˜€๋‹ค [15-17]. ์—ฐ๊ตฌ ๊ธฐ๊ฐ„ ๋™์•ˆ

๋Œ€์ƒ์ž์˜ ์šด๋™๋Ÿ‰์€ ์—ฐ๊ตฌ ์ฐธ์—ฌ ์ด์ „๊ณผ ์ผ์ •ํ•˜๊ฒŒ ์œ ์ง€ํ•˜๋„๋ก ํ•˜์˜€๋‹ค.

ํ†ต๊ณ„์ฒ˜๋ฆฌ์ˆ˜์ง‘ํ•œ ์ž๋ฃŒ์˜ ํ†ต๊ณ„์ฒ˜๋ฆฌ๋Š” SPSS (Statistical Package for Social Sciences version 23.0; SPSS Inc.,

Armonk, NY, USA)๋ฅผ ์ด์šฉํ•˜์—ฌ ๋ถ„์„ํ•˜์˜€๊ณ  ๋ชจ๋“  ๊ฒ€์ • ๊ฒฐ๊ณผ๋Š” ์œ ์˜์ˆ˜์ค€์€ p < 0.05๋กœ ์„ค์ •ํ•˜์—ฌ

ํ†ต๊ณ„์ ์œผ๋กœ ์œ ์˜ํ•˜๋‹ค๊ณ  ๊ฐ„์ฃผํ•˜์˜€๋‹ค.

๋Œ€์ƒ์ž๊ฐ€ ์†ํ•œ ๊ทธ๋ฃน์˜ ์„ฑ๋ณ„์€ ๋นˆ๋„์™€ ๋ฐฑ๋ถ„์œจ๋กœ ํ‘œ์‹œํ•˜์˜€๊ณ , ์‹คํ—˜ ์‹œ์ž‘ ์ „ ๊ทธ๋ฃน ๊ฐ„์˜ ๋‚˜์ด, ์‹ ์žฅ, ์ฒด์ค‘, ์ฒด์„ฑ๋ถ„, ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜, ํ˜ˆ์••, ํ˜ˆ์•ก ๋‚ด ์ง€ํ‘œ ๋“ฑ์˜ ์ฐจ์ด๋ฅผ ๋น„๊ตํ•˜๊ธฐ ์œ„ํ•˜์—ฌ Mann-Whit-

ney U test๋ฅผ ์‹ค์‹œํ•˜์˜€๋‹ค. ๋˜ํ•œ ๊ฐœ์ธ๋ณ„ low GL ์‹์‚ฌ์™€ high GL ์‹์‚ฌ ์‚ฌ์ด์˜ ๋ณ€ํ™”๋Ÿ‰ ๋น„๊ต, ๊ฐ๊ฐ

low GL ์‹์‚ฌ, high GL ์‹์‚ฌ ์„ญ์ทจ์˜ ์ „ยทํ›„ ์ฐจ์ด ๋น„๊ต, ์‹คํ—˜ ์‹œ์ž‘ ์ „ (1์ผ)๊ณผ ์‹คํ—˜ 6์ฃผ ํ›„ (42์ผ)

๋Š” ํ‰๊ท ๊ณผ ํ‘œ์ค€ํŽธ์ฐจ๋ฅผ ์ œ์‹œํ•˜๊ณ , Wilcoxon signed rank test๋ฅผ ์‹ค์‹œํ•˜์—ฌ ์ฐจ์ด๋ฅผ ๊ฒ€์ •ํ•˜์˜€๋‹ค.

๊ฒฐ๊ณผ

๋Œ€์ƒ์ž ํŠน์„ฑ๋ณธ ์—ฐ๊ตฌ์˜ ๋Œ€์ƒ์ž ํŠน์„ฑ ๋ฐ ์ฐธ์—ฌํ•˜๊ธฐ ์ง์ „ ์ธก์ •ํ•œ ์ฒด์„ฑ๋ถ„, ํ˜ˆ์••, ํ˜ˆ์•ก์˜ ๊ฒฐ๊ณผ๋Š” Table 2์™€ ๊ฐ™๋‹ค.

์—ฐ๊ตฌ ๋Œ€์ƒ์ž๋Š” ๋‚จ์„ฑ 10๋ช… (47.6%), ์—ฌ์„ฑ 11๋ช… (52.4%)์œผ๋กœ low โ†’ high GL ๊ทธ๋ฃน์—์„œ ๋‚จ์„ฑ๊ณผ ์—ฌ์„ฑ์€ ๊ฐ๊ฐ 5๋ช…์ด์—ˆ๊ณ , high โ†’ low GL ๊ทธ๋ฃน์€ ๊ฐ๊ฐ 5๋ช…, 6๋ช…์œผ๋กœ ์ด 21๋ช…์ด์—ˆ๋‹ค. ๋Œ€์ƒ์ž์˜ ํŠน์„ฑ์€

์‹คํ—˜ ์‹œ์ž‘ ์ „ ๋‘ ๊ทธ๋ฃน ๊ฐ„์— ๋ชจ๋‘ ์œ ์˜์ ์ธ ์ฐจ์ด๊ฐ€ ์—†์—ˆ๋‹ค.

๋Œ€์ƒ์ž์˜ ์ „์ฒด ํ‰๊ท  ์—ฐ๋ น์€ 24.52 ยฑ 2.40์„ธ๋กœ low โ†’ high GL ๊ทธ๋ฃน๊ณผ high โ†’ low GL ๊ทธ๋ฃน์€ ๊ฐ๊ฐ 25.2 ยฑ 2.10์„ธ, 23.91 ยฑ 2.59์„ธ์˜€๋‹ค. ์ฒด์ค‘์˜ ์ „์ฒด ํ‰๊ท ์€ 75.71 ยฑ 15.06 kg์œผ๋กœ low โ†’ high GL ๊ทธ๋ฃน๊ณผ high โ†’ low GL ๊ทธ๋ฃน์€ ๊ฐ๊ฐ 76.39 ยฑ 16.58 kg, 75.09 ยฑ 14.33 kg์ด์—ˆ์œผ๋ฉฐ, ์ฒด์ง€๋ฐฉ๋Ÿ‰์˜ ์ „์ฒด

ํ‰๊ท ์€ 24.47 ยฑ 4.31 kg์œผ๋กœ low โ†’ high GL ๊ทธ๋ฃน๊ณผ high โ†’ low GL ๊ทธ๋ฃน์€ ๊ฐ๊ฐ 24.05 ยฑ 3.74 kg,

24.85 ยฑ 4.93 kg์ด์—ˆ์œผ๋ฉฐ ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜์˜ ์ „์ฒด ํ‰๊ท ์€ 26.60 ยฑ 2.98 kg/m2์œผ๋กœ low โ†’ high GL ๊ทธ๋ฃน๊ณผ high โ†’ low GL ๊ทธ๋ฃน์€ ๊ฐ๊ฐ 26.52 ยฑ 2.70 kg/m2, 26.67 ยฑ 3.35 kg/m2์ด์—ˆ์œผ๋ฉฐ ์ฒด์„ฑ๋ถ„ ์ธก์ • ๊ฒฐ๊ณผ ๋‘ ๊ทธ๋ฃน ๊ฐ„์˜ ์œ ์˜์ ์ธ ์ฐจ์ด๋Š” ์—†์—ˆ๋‹ค.

ํ˜ˆ์••์˜ ๊ฒฝ์šฐ์—๋Š” ์ˆ˜์ถ•๊ธฐ, ์ด์™„๊ธฐ ํ˜ˆ์••์˜ ์ „์ฒด ํ‰๊ท ์€ ๊ฐ๊ฐ 126.86 ยฑ 23.11 mmHg, 85.10 ยฑ 16.63

mmHg์œผ๋กœ low โ†’ high GL ๊ทธ๋ฃน์€ ๊ฐ๊ฐ 131.80 ยฑ 28.59 mmHg, 88.20 ยฑ 20.62 mmHg์ด์—ˆ๊ณ ,

high โ†’ low GL ๊ทธ๋ฃน์€ 122.36 ยฑ 16.91 mmHg, 82.27 ยฑ 12.34 mmHg์œผ๋กœ ํ˜ˆ์•• ์ธก์ • ๊ฒฐ๊ณผ ๋‘ ๊ทธ๋ฃน

๊ฐ„์˜ ์œ ์˜์ ์ธ ์ฐจ์ด๋Š” ์—†์—ˆ๋‹ค.

ํ˜ˆ์•ก ๊ฒ€์‚ฌ ๊ฒฐ๊ณผ์—์„œ๋Š” ์ค‘์„ฑ์ง€๋ฐฉ์˜ ์ „์ฒด ํ‰๊ท ์€ 92.19 ยฑ 37.69 mg/dL๋กœ low โ†’ high GL ๊ทธ๋ฃน๊ณผ

high โ†’ low GL ๊ทธ๋ฃน์€ ๊ฐ๊ฐ 87.40 ยฑ 32.95 mg/dL, 96.55 ยฑ 42.67 mg/dL์ด์—ˆ๋‹ค. ์ด์ฝœ๋ ˆ์Šคํ…Œ๋กค์˜

468https://doi.org/10.4163/jnh.2020.53.5.464

๋‹น๋ถ€ํ•˜๋Ÿ‰์— ๋”ฐ๋ฅธ ์ฒด์ค‘ ๊ฐ๋Ÿ‰ ํšจ๊ณผ ์—ฐ๊ตฌ

https://e-jnh.org

์ „์ฒด ํ‰๊ท ์€ 169.76 ยฑ 27.90 mg/dL๋กœ low โ†’ high GL ๊ทธ๋ฃน๊ณผ high โ†’ low GL ๊ทธ๋ฃน์€ ๊ฐ๊ฐ 170.60 ยฑ

29.38 mg/dL, 169.00 ยฑ 27.90 mg/dL์ด์—ˆ๋‹ค. ๊ณต๋ณตํ˜ˆ๋‹น์˜ ์ „์ฒด ํ‰๊ท ์€ 88.90 ยฑ 5.88 mg/dL๋กœ low

โ†’ high GL ๊ทธ๋ฃน๊ณผ highโ†’ low GL ๊ทธ๋ฃน์€ ๊ฐ๊ฐ 88.10 ยฑ 5.13 mg/dL, 89.64 ยฑ 6.65 mg/dL์ด์—ˆ๋‹ค.

์ธ์Š๋ฆฐ์˜ ์ „์ฒด ํ‰๊ท ์€ 10.29 ยฑ 4.00 ยตU/mL๋กœ low โ†’ high GL ๊ทธ๋ฃน๊ณผ high โ†’ low GL ๊ทธ๋ฃน์€ ๊ฐ๊ฐ 11.52 ยฑ 4.77 ยตU/mL, 9.17 ยฑ 2.95 ยตU/mL์ด์—ˆ๋‹ค. ์ธ์Š๋ฆฐ์˜ ๋ฏผ๊ฐ์„ฑ๋„ ์˜ˆ์ธก์— ํ™œ์šฉํ•˜๋Š” ์ง€ํ‘œ์ธ

C-peptide์˜ ์ „์ฒด ํ‰๊ท ์€ 2.27 ยฑ 0.58 ng/mL์œผ๋กœ low โ†’ high GL ๊ทธ๋ฃน๊ณผ high โ†’ low GL ๊ทธ๋ฃน์€

๊ฐ๊ฐ 2.40 ยฑ 0.50 ng/mL, 2.15 ยฑ 0.64 ng/mL์ด์—ˆ๋‹ค. ํ˜ˆ์•ก ๊ฒ€์‚ฌ ๊ฒฐ๊ณผ์—์„œ๋„ ๋‘ ๊ทธ๋ฃน ๊ฐ„์˜ ์œ ์˜์ ์ธ ์ฐจ์ด๋Š” ์—†์—ˆ๋‹ค.

๊ฐœ์ธ๋ณ„ low GL๊ณผ high GL ์‹์‚ฌ์—์„œ ๊ทธ๋ฃน ๊ฐ„ ๋ฐ ๊ทธ๋ฃน ๋‚ด ์ „ยทํ›„ ๋น„๊ต๋ชจ๋“  ๋Œ€์ƒ์ž ์ด 21๋ช…์—์„œ low GL ์‹์‚ฌ์™€ high GL ์‹์‚ฌ ์„ญ์ทจ ์ „๊ณผ ํ›„๋ฅผ ๊ฐ๊ฐ ๋น„๊ตํ•œ ๊ฒฐ๊ณผ ๋ฐ 2์ฃผ๊ฐ„์˜ ๋‘ ์‹์‚ฌ ์„ญ์ทจ์— ๋”ฐ๋ฅธ ๋ณ€ํ™”๋Ÿ‰ ์ฐจ์ด๋ฅผ ๋น„๊ตํ•œ ๊ฒฐ๊ณผ๋Š” Table 3์™€ ๊ฐ™๋‹ค.

2์ฃผ๊ฐ„ low GL ์‹์‚ฌ์™€ high GL ์‹์‚ฌ ์„ญ์ทจ์— ๋”ฐ๋ฅธ ๋ณ€ํ™”๋Ÿ‰ ์ฐจ์ด๋ฅผ ๋ณธ ๊ฒฐ๊ณผ ์ฒด์ค‘์€ low GL ์‹์‚ฌ์—์„œ โˆ’2.77 ยฑ 1.09 kg, high GL ์‹์‚ฌ์—์„œ โˆ’1.56 ยฑ 0.78 kg, ์ฒด์ง€๋ฐฉ๋Ÿ‰์€ low GL ์‹์‚ฌ์—์„œ โˆ’1.62 ยฑ 1.19

kg, high GL ์‹์‚ฌ์—์„œ โˆ’0.88 ยฑ 0.91 kg, ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜๋Š” low GL ์‹์‚ฌ์—์„œ โˆ’0.95 ยฑ 0.32 kg/m2, high

GL ์‹์‚ฌ์—์„œ โˆ’0.56 ยฑ 0.27 kg/m2์ด์—ˆ๋‹ค. ์ฒด์ค‘ (p < 0.001), ์ฒด์ง€๋ฐฉ๋Ÿ‰ (p = 0.024), ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜ (p <

0.001)์—์„œ low GL ์‹์‚ฌ ์„ญ์ทจ์— ๋”ฐ๋ฅธ ๊ฐ์†Œ๋Ÿ‰์ด high GL ์‹์‚ฌ ์„ญ์ทจ์— ๋”ฐ๋ฅธ ๊ฐ์†Œ๋Ÿ‰์— ๋น„ํ•ด ์œ ์˜์ ์œผ๋กœ ์ปธ๋‹ค. ๊ทธ๋Ÿฌ๋‚˜ ์ฒด์ง€๋ฐฉ๋ฅ , ์ˆ˜์ถ•๊ธฐยท์ด์™„๊ธฐ ํ˜ˆ์••, ์ค‘์„ฑ์ง€๋ฐฉ, ์ด์ฝœ๋ ˆ์Šคํ…Œ๋กค, HDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, LDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, ๊ณต๋ณตํ˜ˆ๋‹น, ์ธ์Š๋ฆฐ, ์ธ์Š๋ฆฐ HOMA ์ง€์ˆ˜, C-peptide, C-peptide HOMA ์ง€์ˆ˜์—์„œ๋Š” ์œ ์˜์ ์ธ ์ฐจ์ด๊ฐ€ ์—†์—ˆ๋‹ค.

469https://doi.org/10.4163/jnh.2020.53.5.464

๋‹น๋ถ€ํ•˜๋Ÿ‰์— ๋”ฐ๋ฅธ ์ฒด์ค‘ ๊ฐ๋Ÿ‰ ํšจ๊ณผ ์—ฐ๊ตฌ

https://e-jnh.org

Table 2. Subjects' characteristicsCharacteristics All Subjects (n = 21) Low โ†’ high GL group (n = 10) High โ†’ low GL group (n = 11) p-valueSex 0.835

Male 10 (47.6) 5 (50.0) 5 (45.5)Female 11 (52.4)1) 5 (50.0) 6 (54.5)

Age (yrs) 24.52 ยฑ 2.40 25.2 ยฑ 2.10 23.91 ยฑ 2.59 0.282Body weight (kg) 75.71 ยฑ 15.06 76.39 ยฑ 16.58 75.09 ยฑ 14.33 0.809Body fat mass (kg) 24.47 ยฑ 4.31 24.05 ยฑ 3.74 24.85 ยฑ 4.93 0.809Body mass index (kg/m2) 26.60 ยฑ 2.98 26.52 ยฑ 2.70 26.67 ยฑ 3.35 0.918Percent body fat (%) 32.82 ยฑ 4.82 32.09 ยฑ 4.62 33.49 ยฑ 5.13 0.426Blood pressure (mmHg)

Systolic 126.86 ยฑ 23.11 131.80 ยฑ 28.59 122.36 ยฑ 16.91 0.557Diastolic 85.10 ยฑ 16.63 88.20 ยฑ 20.62 82.27 ยฑ 12.34 0.605

Lipid profile (mg/dL)Triglyceride 92.19 ยฑ 37.69 87.40 ยฑ 32.95 96.55 ยฑ 42.67 0.557Total cholesterol 169.76 ยฑ 27.90 170.60 ยฑ 29.38 169.00 ยฑ 27.90 0.918HDL-cholesterol 56.10 ยฑ 9.53 57.10 ยฑ 11.11 55.18 ยฑ 8.28 0.863LDL-cholesterol 104.86 ยฑ 30.89 105.70 ยฑ 35.51 104.09 ยฑ 27.78 0.918

Fasting glucose (mg/dL) 88.90 ยฑ 5.88 88.10 ยฑ 5.13 89.64 ยฑ 6.65 0.654HbA1c1 (%) 5.39 ยฑ 0.24 5.42 ยฑ 0.27 5.36 ยฑ 0.22 0.809Insulin (ยตU/mL) 10.29 ยฑ 4.00 11.52 ยฑ 4.77 9.17 ยฑ 2.95 0.197

HOMA-IR-Insulin1) 1.26 ยฑ 0.45 1.34 ยฑ 0.52 1.19 ยฑ 0.39 0.468C-peptide (ng/mL) 2.27 ยฑ 0.58 2.40 ยฑ 0.50 2.15 ยฑ 0.64 0.387

HOMA-IR-C-peptide1) 1.52 ยฑ 0.51 1.74 ยฑ 0.37 1.58 ยฑ 0.50 0.468Data are shown as mean ยฑ SD or number (%).GL, glycemic load; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HbA1c1, hemoglobin A1c; HOMA-IR-Insulin, homeostasis model assessment to quantify insulin resistance; HOMA-IR-C-peptide, homeostasis model assessment to quantify insulin resistance C-peptide.1)Homeostasis assessment model (HOMA2) calculator was used.

Low GL ์‹์‚ฌ์™€ high GL ์‹์‚ฌ ์„ญ์ทจ ์ „ยทํ›„๋ฅผ ๊ฐ ์‹์‚ฌ๋ณ„๋กœ ๋น„๊ตํ•œ ๊ฒฐ๊ณผ ์ฒด์ค‘์€ low GL ์‹์‚ฌ ์„ญ์ทจ

์ „๊ณผ ํ›„๋Š” ๊ฐ๊ฐ 75.31 ยฑ 15.22 kg, 72.54 ยฑ 14.44 kg, high GL ์‹์‚ฌ๋Š” ๊ฐ๊ฐ 75.06 ยฑ 14.79 kg, 73.50 ยฑ

14.70 kg, ์ฒด์ง€๋ฐฉ๋Ÿ‰์€ low GL ์‹์‚ฌ ์„ญ์ทจ ์ „ยทํ›„๋Š” 24.08 ยฑ 4.36 kg, 22.46 ยฑ 3.81 kg, high GL ์‹์‚ฌ๋Š”

๊ฐ๊ฐ 23.92 ยฑ 4.17 kg, 23.05 ยฑ 4.14 kg, ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜๋Š” low GL ์‹์‚ฌ ์„ญ์ทจ ์ „ยทํ›„๋Š” 26.44 ยฑ 3.05 kg/m2,

25.49 ยฑ 2.86 kg/m2, high GL ์‹์‚ฌ๋Š” ๊ฐ๊ฐ 26.38 ยฑ 2.95 kg/m2, 25.82 ยฑ 2.99 kg/m2์ด์—ˆ๋‹ค. Low GL

์‹์‚ฌ, high GL ์‹์‚ฌ์—์„œ ์ฒด์ค‘ (p < 0.001, p < 0.001), ์ฒด์ง€๋ฐฉ๋Ÿ‰ (p < 0.001, p = 0.001), ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜ (p < 0.001, p < 0.001)๊ฐ€ ๊ฐ ์‹์‚ฌ ์„ญ์ทจ ์ „๋ณด๋‹ค ํ›„์— ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œ๋˜์—ˆ๋‹ค. ์ฒด์ง€๋ฐฉ๋ฅ ์€ low

GL ์‹์‚ฌ์—์„œ ์ „๊ณผ ํ›„ ๊ฐ๊ฐ 32.46 ยฑ 4.77%, 31.57 ยฑ 5.09%๋กœ low GL ์‹์‚ฌ์—์„œ๋งŒ ์ฒด์ง€๋ฐฉ๋ฅ  (p =

0.005)์ด ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œ๋˜์—ˆ๋‹ค.

ํ˜ˆ์••์˜ ๊ฒฝ์šฐ์—๋Š” low GL ์‹์‚ฌ์—์„œ ์„ญ์ทจ ์ „๊ณผ ํ›„์˜ ์ด์™„๊ธฐ ํ˜ˆ์••์€ ๊ฐ๊ฐ 83.10 ยฑ 16.48 mmHg,

78.67 ยฑ 12.75 mmHg์œผ๋กœ ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œ๋˜์—ˆ๋‹ค (p = 0.006).

ํ˜ˆ์•ก ๊ฒ€์‚ฌ ๊ฒฐ๊ณผ์—์„œ ์ด์ฝœ๋ ˆ์Šคํ…Œ๋กค์€ low GL ์‹์‚ฌ ์„ญ์ทจ ์ „๊ณผ ํ›„๋Š” ๊ฐ๊ฐ 173.00 ยฑ 27.22 mg/dL,

159.43 ยฑ 26.67 mg/dL, high GL ์‹์‚ฌ๋Š” ๊ฐ๊ฐ 171.14 ยฑ 27.16 mg/dL, 159.29 ยฑ 23.98 mg/dL, HDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค์€ low GL ์‹์‚ฌ ์„ญ์ทจ ์ „๊ณผ ํ›„๋Š” ๊ฐ๊ฐ 56.52 ยฑ 9.40 mg/dL, 52.05 ยฑ 9.53 mg/dL, high GL ์‹์‚ฌ๋Š” ๊ฐ๊ฐ 55.71 ยฑ 9.64 mg/dL, 50.57 ยฑ 9.68 mg/dL, ๊ณต๋ณตํ˜ˆ๋‹น์€ low GL ์‹์‚ฌ ์„ญ์ทจ ์ „๊ณผ ํ›„๋Š” ๊ฐ๊ฐ

88.19 ยฑ 7.13 mg/dL, 80.48 ยฑ 5.75 mg/dL, high GL ์‹์‚ฌ๋Š” ๊ฐ๊ฐ 87.62 ยฑ 7.48 mg/dL, 81.76 ยฑ 6.20 mg/dL,

C-peptide HOMA ์ง€์ˆ˜๋Š” low GL ์‹์‚ฌ ์„ญ์ทจ ์ „๊ณผ ํ›„๋Š” ๊ฐ๊ฐ 1.64 ยฑ 0.51, 1.35 ยฑ 0.44, high GL ์‹์‚ฌ๋Š” ๊ฐ๊ฐ 1.71 ยฑ 0.49, 1.46 ยฑ 0.48์ด์—ˆ๋‹ค. Low GL ์‹์‚ฌ, high GL ์‹์‚ฌ์—์„œ ์ด์ฝœ๋ ˆ์Šคํ…Œ๋กค (p = 0.001,

p = 0.005), HDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค (p = 0.004, p = 0.003), ๊ณต๋ณตํ˜ˆ๋‹น (p < 0.001, p = 0.001), C-peptide

HOMA ์ง€์ˆ˜ (p = 0.016, p = 0.023)๊ฐ€ ๊ฐ ์‹์‚ฌ ์„ญ์ทจ ์ „๋ณด๋‹ค ํ›„์— ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œ๋˜์—ˆ๋‹ค. ์ค‘์„ฑ์ง€๋ฐฉ์€ low GL ์‹์‚ฌ์—์„œ ์ „๊ณผ ํ›„ ๊ฐ๊ฐ 93.95 ยฑ 37.84 mg/dL, 71.38 ยฑ 27.61 mg/dL, LDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค์€

๊ฐ๊ฐ 105.38 ยฑ 29.58 mg/dL, 98.19 ยฑ 27.29 mg/dL, C-peptide๋Š” high GL ์‹์‚ฌ์—์„œ ์ „๊ณผ ํ›„ ๊ฐ๊ฐ 2.35

470https://doi.org/10.4163/jnh.2020.53.5.464

๋‹น๋ถ€ํ•˜๋Ÿ‰์— ๋”ฐ๋ฅธ ์ฒด์ค‘ ๊ฐ๋Ÿ‰ ํšจ๊ณผ ์—ฐ๊ตฌ

https://e-jnh.org

Table 3. Body composition, blood pressure and blood lipids changes following the isocaloric low GL diet and high GL dietAll subjects Low GL group High GL group Low GL group High GL group

Pre-test (n = 21) Post-test (n = 21) p-value Pre-test (n = 21) Post-test (n = 21) p-value ฮ”change1) (n = 21) ฮ”change1) (n = 21) p-valueBody weight (kg) 75.31 ยฑ 15.22 72.54 ยฑ 14.44 < 0.001* 75.06 ยฑ 14.79 73.50 ยฑ 14.70 < 0.001* โˆ’2.77 ยฑ 1.09 โˆ’1.56 ยฑ 0.78 < 0.001*Body fat mass (kg) 24.08 ยฑ 4.36 22.46 ยฑ 3.81 < 0.001* 23.92 ยฑ 4.17 23.05 ยฑ 4.14 0.001* โˆ’1.62 ยฑ 1.19 โˆ’0.88 ยฑ 0.91 0.024*Body mass inbody (kg/m2) 26.44 ยฑ 3.05 25.49 ยฑ 2.86 < 0.001* 26.38 ยฑ 2.95 25.82 ยฑ 2.99 < 0.001* โˆ’0.95 ยฑ 0.32 โˆ’0.56 ยฑ 0.27 < 0.001*Percent body fat (%) 32.46 ยฑ 4.77 31.57 ยฑ 5.09 0.005* 32.41 ยฑ 4.96 31.91 ยฑ 5.17 0.073 โˆ’0.89 ยฑ 1.23 โˆ’0.50 ยฑ 1.08 0.237Blood pressure (mmHg)

Systolic 124.14 ยฑ 22.35 120.86 ยฑ 16.84 0.094 122.86 ยฑ 17.66 120.24 ยฑ 16.97 0.169 โˆ’3.29 ยฑ 7.60 โˆ’2.62 ยฑ 8.29 0.807Diastolic 83.10 ยฑ 16.48 78.67 ยฑ 12.75 0.006* 82.10 ยฑ 14.76 80.29 ยฑ 12.84 0.331 โˆ’4.43 ยฑ 7.60 โˆ’1.81 ยฑ 8.86 0.171

Lipid profile (mg/dL)Triglyceride 93.95 ยฑ 37.84 71.38 ยฑ 27.61 0.008* 100.19 ยฑ 49.37 100.43 ยฑ 45.06 0.945 โˆ’22.57 ยฑ 30.12 0.24 ยฑ 49.95 0.085Total cholesterol 173.00 ยฑ 27.22 159.43 ยฑ 26.67 0.001* 171.14 ยฑ 27.16 159.29 ยฑ 23.98 0.005* โˆ’13.57 ยฑ 13.53 โˆ’11.86 ยฑ 16.49 0.972HDL-cholesterol 56.52 ยฑ 9.40 52.05 ยฑ 9.53 0.004* 55.71 ยฑ 9.64 50.57 ยฑ 9.68 0.003* โˆ’4.48 ยฑ 5.67 โˆ’5.14 ยฑ 6.29 0.809LDL-cholesterol 105.38 ยฑ 29.58 98.19 ยฑ 27.29 0.019* 104.29 ยฑ 27.50 97.62 ยฑ 24.93 0.056 โˆ’7.19 ยฑ 11.91 โˆ’6.67 ยฑ 13.39 0.828

Fasting glucose (mg/dL) 88.19 ยฑ 7.13 80.48 ยฑ 5.75 < 0.001* 87.62 ยฑ 7.48 81.76 ยฑ 6.20 0.001* โˆ’7.71 ยฑ 6.85 โˆ’5.86 ยฑ 6.04 0.370Insulin (ยตU/mL) 10.35 ยฑ 5.25 8.54 ยฑ 4.18 0.211 10.75 ยฑ 4.26 10.29 ยฑ 6.11 0.578 โˆ’1.81 ยฑ 6.01 โˆ’0.47 ยฑ 6.23 0.702

HOMA-IR-Insulin2) 1.27 ยฑ 0.63 1.08 ยฑ 0.52 0.258 1.37 ยฑ 0.53 1.29 ยฑ 0.75 0.444 โˆ’0.19 ยฑ 0.70 โˆ’0.09 ยฑ 0.77 0.848C-peptide (ng/mL) 2.20 ยฑ 0.66 1.91 ยฑ 0.60 0.052 2.35 ยฑ 0.66 2.05 ยฑ 0.67 0.034* โˆ’0.29 ยฑ 0.62 โˆ’0.30 ยฑ 0.64 0.835

HOMA-IR-C-peptide2) 1.64 ยฑ 0.51 1.35 ยฑ 0.44 0.016* 1.71 ยฑ 0.49 1.46 ยฑ 0.48 0.023* โˆ’0.29 ยฑ 0.49 โˆ’0.25 ยฑ 0.47 0.794Data are shown as mean ยฑ SD.GL, glycemic load; HDL, high-density lipoprotein; LDL, low-density lipoprotein; HOMA-IR-Insulin, homeostasis model assessment to quantify insulin resistance; HOMA-IR-C-peptide, homeostasis model assessment to quantify insulin resistance C-peptide.1)Pre-test post-test changes in response to the meal. 2)Homeostasis assessment model (HOMA2) calculator was used.*p < 0.05.

ยฑ 0.66 ng/mL, 2.05 ยฑ 0.67 ng/mL์œผ๋กœ low GL ์‹์‚ฌ์—์„œ๋งŒ ์ค‘์„ฑ์ง€๋ฐฉ (p = 0.008)๊ณผ LDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค (p = 0.019), high GL ์‹์‚ฌ์—์„œ๋งŒ C-peptide (p = 0.034)๊ฐ€ ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œ๋˜์—ˆ๋‹ค.

์ฆ‰, low GL ์‹์‚ฌ์—์„œ๋Š” ์ฒด์ค‘, ์ฒด์ง€๋ฐฉ๋Ÿ‰, ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜, ์ฒด์ง€๋ฐฉ๋ฅ , ์ด์™„๊ธฐ ํ˜ˆ์••, ์ค‘์„ฑ์ง€๋ฐฉ, ์ด์ฝœ๋ ˆ์Šคํ…Œ๋กค, HDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, LDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, ๊ณต๋ณตํ˜ˆ๋‹น, C-peptide HOMA ์ง€์ˆ˜์—์„œ ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œ๋˜์—ˆ๊ณ , high GL ์‹์‚ฌ๋Š” ์ฒด์ค‘, ์ฒด์ง€๋ฐฉ๋Ÿ‰, ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜, ์ด์ฝœ๋ ˆ์Šคํ…Œ๋กค, HDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, ๊ณต๋ณตํ˜ˆ๋‹น, C-peptide, C-peptide HOMA ์ง€์ˆ˜์—์„œ ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œ๋˜์—ˆ๋‹ค.

์‹คํ—˜ ์ „๊ณผ ํ›„ ๋น„๊ต๋ชจ๋“  ๋Œ€์ƒ์ž (n = 21)์—์„œ ์‹คํ—˜ ์‹œ์ž‘ ์ „ (1์ผ)๊ณผ ์‹คํ—˜ 6์ฃผ ํ›„ (42์ผ)๋ฅผ ๋น„๊ตํ•œ ๊ฒฐ๊ณผ๋Š” Table 4์™€

๊ฐ™๋‹ค. ์ค‘๊ฐ„ 2์ฃผ๋ฅผ ์ œ์™ธํ•œ ์ฒ˜์Œ 2์ฃผ์™€ ๋งˆ์ง€๋ง‰ 2์ฃผ (4์ฃผ) ๊ฐ„์˜ low GL๊ณผ high GL ์‹์‚ฌ ๊ตฌ์„ฑ์— ์ƒ๊ด€์—†์ด ๊ฐ์†Œ๋œ ์—ด๋Ÿ‰ ์„ญ์ทจ ๊ฒฐ๊ณผ ์ „๋ฐ˜์ ์œผ๋กœ ๋Œ€๋ถ€๋ถ„์˜ ์ง€ํ‘œ๊ฐ€ ๊ฐ์†Œ๋˜์—ˆ๋‹ค.

์‹คํ—˜ ํ›„์˜ ์ฒด์ค‘์˜ ๋ณ€ํ™”๋Ÿ‰์€ โˆ’3.17 ยฑ 1.47 kg (p < 0.001), ์ฒด์ง€๋ฐฉ๋Ÿ‰์€ โˆ’2.15 ยฑ 1.53 kg (p < 0.001),

์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜๋Š” โˆ’1.11 ยฑ 0.49 kg/m2 (p < 0.001), ์ฒด์ง€๋ฐฉ๋ฅ ์—์„œ๋Š” โˆ’1.42 ยฑ 1.53% (p = 0.001)๋กœ ์ฒด์„ฑ๋ถ„ ์ธก์ • ๊ฒฐ๊ณผ ์‹คํ—˜ ํ›„์— ๋ชจ๋‘ ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œ๋˜์—ˆ๋‹ค. ํ˜ˆ์••์˜ ๊ฒฝ์šฐ ์‹คํ—˜ ํ›„ ์ˆ˜์ถ•๊ธฐ ํ˜ˆ์••์˜ ๋ณ€ํ™”๋Ÿ‰์€ โˆ’8.19 ยฑ 11.26 mmHg (p = 0.003), ์ด์™„๊ธฐ ํ˜ˆ์••์˜ ๋ณ€ํ™”๋Ÿ‰์€ โˆ’5.86 ยฑ 7.28 mmHg (p = 0.002)

์œผ๋กœ ํ˜ˆ์••์—์„œ๋„ ์‹คํ—˜ ํ›„์— ๋ชจ๋‘ ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œ๋˜์—ˆ๋‹ค. ํ˜ˆ์•ก ๊ฒ€์‚ฌ ๊ฒฐ๊ณผ์—์„œ๋Š” ์ด์ฝœ๋ ˆ์Šคํ…Œ๋กค์˜ ์‹คํ—˜ ํ›„ ๋ณ€ํ™”๋Ÿ‰์€ โˆ’9.43 ยฑ 15.35 mg/dL (p = 0.018), HDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค์€ โˆ’3.24 ยฑ 5.79 mg/dL

(p = 0.031), LDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค์€ โˆ’6.38 ยฑ 13.08 mg/dL (p = 0.046), ๊ณต๋ณตํ˜ˆ๋‹น์€ โˆ’8.81 ยฑ 5.73 mg/dL

(p < 0.001), C-peptide๋Š” โˆ’0.33 ยฑ 0.46 ng/mL (p = 0.006), C-peptide HOMA ์ง€์ˆ˜๋Š” โˆ’0.29 ยฑ 0.34

(p = 0.002)๋กœ ์‹คํ—˜ ์ „๋ณด๋‹ค ์‹คํ—˜ ํ›„์— ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œ๋˜์—ˆ๋‹ค. ๋ฐ˜๋ฉด์— ์ค‘์„ฑ์ง€๋ฐฉ, ์ธ์Š๋ฆฐ, ์ธ์Š๋ฆฐ HOMA ์ง€์ˆ˜๋Š” ์œ ์˜์ ์ธ ์ฐจ์ด๊ฐ€ ์—†์—ˆ๋‹ค.

471https://doi.org/10.4163/jnh.2020.53.5.464

๋‹น๋ถ€ํ•˜๋Ÿ‰์— ๋”ฐ๋ฅธ ์ฒด์ค‘ ๊ฐ๋Ÿ‰ ํšจ๊ณผ ์—ฐ๊ตฌ

https://e-jnh.org

Table 4. Body composition, blood pressure and blood lipids changes following the baseline and 6th weekAll subjects Baseline (n = 21) Week 6 (n = 21) Change1) p-valueBody weight (kg) 75.71 ยฑ 15.06 72.54 ยฑ 14.47 โˆ’3.17 ยฑ 1.47 < 0.001*Body fat mass (kg) 24.47 ยฑ 4.31 22.32 ยฑ 3.76 โˆ’2.15 ยฑ 1.53 < 0.001*Body mass index (kg/m2) 26.60 ยฑ 2.98 25.49 ยฑ 2.88 โˆ’1.11 ยฑ 0.49 < 0.001*Percent body fat (%) 32.82 ยฑ 4.82 31.40 ยฑ 5.12 โˆ’1.42 ยฑ 1.53 0.001*Blood pressure (mmHg)

Systolic 126.86 ยฑ 23.11 118.67 ยฑ 16.54 โˆ’8.19 ยฑ 11.26 0.003*Diastolic 85.10 ยฑ 16.63 79.24 ยฑ 13.32 โˆ’5.86 ยฑ 7.28 0.002*

Lipid profile (mg/dL)Triglyceride 92.19 ยฑ 37.69 78.33 ยฑ 33.33 โˆ’13.86 ยฑ 40.07 0.170Total cholesterol 169.76 ยฑ 27.90 160.33 ยฑ 23.83 โˆ’9.43 ยฑ 15.35 0.018*HDL-cholesterol 56.10 ยฑ 9.53 52.86 ยฑ 10.30 โˆ’3.24 ยฑ 5.79 0.031*LDL-cholesterol 105.38 ยฑ 29.58 96.95 ยฑ 25.08 โˆ’6.38 ยฑ 13.08 0.046*

Fasting glucose 88.90 ยฑ 5.88 80.10 ยฑ 6.62 โˆ’8.81 ยฑ 5.73 < 0.001*HbA1c1 5.39 ยฑ 0.24 5.18 ยฑ 0.24 โˆ’0.21 ยฑ 0.16 0.001*Insulin (ยตU/mL) 9.91 ยฑ 3.84 9.89 ยฑ 6.49 โˆ’0.40 ยฑ 4.66 0.244

HOMA-IR-Insulin2) 1.28 ยฑ 0.49 1.24 ยฑ 0.80 โˆ’0.02 ยฑ 0.59 0.259C-peptide (ng/mL) 2.21 ยฑ 0.55 1.94 ยฑ 0.74 โˆ’0.33 ยฑ 0.46 0.006*

HOMA-IR-C-peptide2) 1.66 ยฑ 0.40 1.34 ยฑ 0.56 โˆ’0.29 ยฑ 0.34 0.002*

Data are shown as mean ยฑ SD.HDL, high-density lipoprotein; LDL, low-density lipoprotein; HbA1c1, hemoglobin A1c; HOMA-IR-Insulin, homeostasis model assessment to quantify insulin resistance; HOMA-IR-C-peptide, homeostasis model assessment to quantify insulin resistance C-peptide.1)From baseline by post-hoc. 2)Homeostasis assessment model (HOMA2) calculator was used.*p < 0.05.

๊ณ ์ฐฐ์ฒด์ค‘ ๊ฐ๋Ÿ‰์„ ์œ„ํ•ด์„œ๋Š” ์—ด๋Ÿ‰๋ฟ๋งŒ ์•„๋‹ˆ๋ผ ํƒ„์ˆ˜ํ™”๋ฌผ ๋˜๋Š” ์ง€๋ฐฉ ์„ญ์ทจ๋ฅผ ์ œํ•œํ•˜๋„๋ก ๊ถŒ๊ณ ๋˜์–ด ์™”์œผ๋ฉฐ ์ตœ๊ทผ ๊ณ ํƒ„์ˆ˜ํ™”๋ฌผ ์‹์‚ฌ์— ์˜ํ•ด ๋‹น๋‡จ๋ณ‘, ์‹ฌํ˜ˆ๊ด€ ์งˆํ™˜, ๋น„๋งŒ ๋“ฑ ์ƒํ™œ์Šต๊ด€๋ณ‘์˜ ์œ„ํ—˜์ด ์ฆ๊ฐ€ํ•˜๊ณ  ์‹์‚ฌ์˜ ํ˜ˆ๋‹น์ง€์ˆ˜์™€ ์ฒด์ค‘ ์‚ฌ์ด์˜ ์–‘์˜ ๊ด€๊ณ„๊ฐ€ ์žˆ๋‹ค๋Š” ์—ฐ๊ตฌ๊ฒฐ๊ณผ๋“ค์ด ๋ณด๊ณ ๋˜๊ณ  ์žˆ์–ด ํƒ„์ˆ˜ํ™”๋ฌผ์„ ์ œํ•œํ•œ ์‹์ด๊ฐ€ ์ฃผ๋ชฉ๋ฐ›๊ณ  ์žˆ๋‹ค [4,18]. ๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ํ•œ๊ตญ์ธ์˜ ์ผ๋ฐ˜์‹์‚ฌ์™€ ์œ ์‚ฌํ•œ ๋†’์€ ์ˆ˜์ค€์˜ ๋‹น๋ถ€ํ•˜๋Ÿ‰์„ ๊ฐ€์ง„ ์‹์‚ฌ (high GL)์™€ ๋‹น๋ถ€ํ•˜๋Ÿ‰์ด ๋‚ฎ๊ฒŒ (low GL) ์„ค๊ณ„๋œ ์‹์‚ฌ๋ฅผ ๊ฐ๊ฐ

2์ฃผ ๋™์•ˆ ์„ญ์ทจํ•˜์—ฌ ์‹คํ—˜ ์ „๊ณผ ํ›„์˜ ์ฒด์ค‘, ์ฒด์ง€๋ฐฉ, ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜, ํ˜ˆ์•• ๋ฐ ํ˜ˆ์•ก ๋‚ด ์ƒํ™œ์Šต๊ด€๋ณ‘ ์œ„ํ—˜ ์ง€ํ‘œ ๋“ฑ์„ ์‚ดํŽด๋ณด์•˜๋‹ค.

์ฒด์ค‘๊ฐ์†Œ๋ฅผ ๋ชฉํ‘œ๋กœ ์—ด๋Ÿ‰์„ ์ œํ•œํ•˜์˜€์œผ๋‚˜ ๋™๋“ฑํ•œ ์—ด๋Ÿ‰์„ ๊ฐ€์ง„ high GL (n = 21)๊ณผ low GL (n =

21) ์‹์‚ฌ ์„ญ์ทจ ์ „๊ณผ ํ›„์˜ ๋ณ€ํ™”๋Ÿ‰์„ ๋น„๊ตํ•œ ๊ฒฐ๊ณผ low GL ์‹์‚ฌ์—์„œ ์ฒด์ค‘, ์ฒด์ง€๋ฐฉ๋Ÿ‰, ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜์˜ ๊ฐ์†Œ๋Ÿ‰์ด high GL ์‹์‚ฌ์˜ ๊ฐ์†Œ๋Ÿ‰์— ๋น„ํ•ด ์œ ์˜์ ์œผ๋กœ ์ปธ๊ณ , ํ˜ˆ์••, ์ค‘์„ฑ์ง€๋ฐฉ, ์ด์ฝœ๋ ˆ์Šคํ…Œ๋กค, HDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, LDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, ๊ณต๋ณตํ˜ˆ๋‹น, ์ธ์Š๋ฆฐ, ์ธ์Š๋ฆฐ HOMA ์ง€์ˆ˜, C-peptide,

C-peptide HOMA ์ง€์ˆ˜์—์„œ๋Š” ์ฐจ์ด๊ฐ€ ์—†์—ˆ๋‹ค. ๊ฐ ์‹์‚ฌ์˜ ์ „๊ณผ ํ›„ ๋น„๊ต์—์„œ๋Š” low GL ์‹์‚ฌ์—์„œ๋Š” ์ฒด์ค‘, ์ฒด์ง€๋ฐฉ๋Ÿ‰, ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜, ์ฒด์ง€๋ฐฉ๋ฅ , ์ด์™„๊ธฐํ˜ˆ์••, ์ค‘์„ฑ์ง€๋ฐฉ, ์ด์ฝœ๋ ˆ์Šคํ…Œ๋กค, HDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, LDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, ๊ณต๋ณตํ˜ˆ๋‹น, C-peptide HOMA ์ง€์ˆ˜์—์„œ, high GL ์‹์‚ฌ์—์„œ๋Š” ์ฒด์ค‘, ์ฒด์ง€๋ฐฉ๋Ÿ‰, ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜, ์ด์ฝœ๋ ˆ์Šคํ…Œ๋กค, HDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, ๊ณต๋ณตํ˜ˆ๋‹น, C-peptide, C-peptide HOMA

์ง€์ˆ˜์—์„œ ์‹์‚ฌ ์„ญ์ทจ ์ „๋ณด๋‹ค ํ›„์— ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œํ•œ ๊ฒƒ์„ ๋ณผ ์ˆ˜ ์žˆ์—ˆ๋‹ค. Noakes ๋“ฑ [19]์˜ ๋™๋“ฑํ•œ ์นผ๋กœ๋ฆฌ์˜ ์ €ํƒ„์ˆ˜ํ™”๋ฌผยท๊ณ ํฌํ™”์ง€๋ฐฉ์˜ ์‹์‚ฌ์™€ ๊ณ ํƒ„์ˆ˜ํ™”๋ฌผยท์ €ํฌํ™”์ง€๋ฐฉ์˜ ์‹์‚ฌ ์‚ฌ์ด์— ์‹ ์ฒด ๊ตฌ์„ฑ๊ณผ ์‹ฌํ˜ˆ๊ด€๊ณ„์งˆํ™˜ ์œ„ํ—˜์„ ๋น„๊ตํ•œ ์—ฐ๊ตฌ์—์„œ 12์ฃผ ๋™์•ˆ ๊ฐœ์ธ์˜ ํ•„์š” ์—ด๋Ÿ‰์˜ 30% ์ค„์ธ ๋งค์šฐ ๋‚ฎ์€ ํƒ„์ˆ˜ํ™”๋ฌผยท๊ณ ํฌํ™”์ง€๋ฐฉ์˜ ์‹์‚ฌ๊ฐ€ ๊ณ ํƒ„์ˆ˜ํ™”๋ฌผยท์ €ํฌํ™”์ง€๋ฐฉ์˜ ์‹์‚ฌ๋ณด๋‹ค ์œ ์˜์ ์œผ๋กœ ์ฒด์ค‘ ๊ฐ์†Œ ๋น„์œจ์ด ๋” ํฐ ๊ฒƒ์œผ๋กœ ๋ณด๊ณ ๋˜์—ˆ๊ณ  (9.2% vs. 7.0%), Foster ๋“ฑ [20]์˜ ๋น„๋งŒ์„ ์œ„ํ•œ ์ €ํƒ„์ˆ˜ํ™”๋ฌผ์˜ ๋ฌด์ž‘์œ„ ์‹œํ—˜์„ ํ•œ ์—ฐ๊ตฌ์—์„œ 6๊ฐœ์›” ๋™์•ˆ ์ €ํƒ„์ˆ˜ํ™”๋ฌผ ์‹์‚ฌ๊ฐ€ ๊ณ ํƒ„์ˆ˜ํ™”๋ฌผ์˜ ์ผ๋ฐ˜ ์‹์‚ฌ๋ณด๋‹ค ์œ ์˜์ ์œผ๋กœ ์ฒด์ค‘์„ ๊ฐ์†Œ์‹œํ‚จ ๊ฒƒ์œผ๋กœ ๋ณด๊ณ ํ•˜๊ณ  ์žˆ์–ด ์ด๋Š” ๊ณ ํƒ„์ˆ˜ํ™”๋ฌผ ์‹์‚ฌ๋ณด๋‹ค ์ €ํƒ„์ˆ˜ํ™”๋ฌผ ์‹์‚ฌ๊ฐ€ ์ฒด์ค‘ ๊ฐ์†Œ์— ๋” ํšจ๊ณผ๋ฅผ ๋ณด์ธ ๋ณธ ์—ฐ๊ตฌ์™€ ์œ ์‚ฌํ•œ ๊ฒฐ๊ณผ๋ผ ํ•˜๊ฒ ๋‹ค. ์„œ๊ตฌ์ธ๋“ค์„ ๋Œ€์ƒ์œผ๋กœ ํ•œ ๋˜ ๋‹ค๋ฅธ ์—ฐ๊ตฌ์—์„œ ์ €ํƒ„์ˆ˜ํ™”๋ฌผ๊ณผ ๊ณ ํƒ„์ˆ˜ํ™”๋ฌผ ์‹์‚ฌ ์ „ยทํ›„์— ๊ฐ๊ฐ ์ฒด์ง€๋ฐฉ๋Ÿ‰์ด ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œํ•˜์˜€๊ณ , ์ €ํƒ„์ˆ˜ํ™”๋ฌผ๊ณผ ์ €์ง€๋ฐฉ ์‹์‚ฌ์˜ ํšจ๊ณผ๋ฅผ ๋ณธ ์—ฐ๊ตฌ์—์„œ๋„ ์‹์‚ฌ ์ „ยทํ›„์— ์ฒด์ง€๋ฐฉ๋Ÿ‰์ด ๊ฐ๊ฐ ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œํ•œ ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ์œผ๋‚˜ ์ด๋“ค ์—ฐ๊ตฌ์—์„œ๋Š” ์ €ํƒ„์ˆ˜ํ™”๋ฌผ, ๊ณ ํƒ„์ˆ˜ํ™”๋ฌผ๋กœ

๊ตฌ์„ฑ๋œ ๋‘ ์‹์‚ฌ ์„ญ์ทจ์— ๋”ฐ๋ฅธ ๋ณ€ํ™”๋Ÿ‰์—์„œ๋Š” ์œ ์˜์ ์ธ ์ฐจ์ด๊ฐ€ ๋‚˜ํƒ€๋‚˜์ง€ ์•Š์•˜๋‹ค [18,21]. ๊ฐ ์‹์‚ฌ ์ „ยทํ›„์— ์œ ์˜์ ์œผ๋กœ ์ฒด์ง€๋ฐฉ๋Ÿ‰์ด ๊ฐ์†Œํ•œ ๊ฒƒ์€ ๋‹ค๋ฅธ ์—ฐ๊ตฌ ๊ฒฐ๊ณผ์™€ ์œ ์‚ฌํ•˜๋‚˜ ์•ž์„  ์—ฐ๊ตฌ์™€ ๋‹ฌ๋ฆฌ ๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ๋‘ ์‹์‚ฌ ์‚ฌ์ด์˜ ๋ณ€ํ™”๋Ÿ‰ ๋น„๊ต์—์„œ๋„ low GL์„ ๊ฐ€์ง„ ์‹์‚ฌ๊ฐ€ ์œ ์˜์ ์œผ๋กœ ๋ณ€ํ™”๋Ÿ‰์ด ํฌ๊ณ  high GL ์‹์‚ฌ์— ๋น„ํ•ด low GL ์‹์‚ฌ๊ฐ€ ์ฒด์ง€๋ฐฉ๋Ÿ‰ ๊ฐ์†Œ์— ๋” ํšจ๊ณผ์ ์ด์—ˆ๋‹ค. ์ด๋Š” ํ•œ๊ตญ์ธ์—๊ฒŒ low GL ์‹์‚ฌ๊ฐ€ high GL ์‹์‚ฌ์— ๋น„ํ•ด ์ฒด์ค‘, ์ฒด์ง€๋ฐฉ๋Ÿ‰, ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜ ๊ฐ๋Ÿ‰ ํšจ๊ณผ๊ฐ€ ํฐ ๊ฒƒ์„

ํ™•์ธํ•œ ์‚ฌ๋ก€๋ผ ํ•  ์ˆ˜ ์žˆ๋‹ค.

๋ณธ ์—ฐ๊ตฌ์˜ ํƒ„์ˆ˜ํ™”๋ฌผ, ๋‹จ๋ฐฑ์งˆ, ์ง€๋ฐฉ ์กฐ์„ฑ์€ low GL ์‹์‚ฌ์—์„œ๋Š” ํ‰๊ท  44.7%, 35.3%, 20%, high

GL ์‹์‚ฌ๋Š” ํ‰๊ท  77.3%, 13%, 10%๋กœ ํƒ„์ˆ˜ํ™”๋ฌผ์˜ ์–‘์€ ๊ฐ๊ฐ 158.3โ€“227.7 g๊ณผ 242.2โ€“353.4 g์ด์—ˆ๋‹ค. ๊ณ ๋„๋น„๋งŒ ์ฒญ์†Œ๋…„์˜ ์ฒด์ค‘ ๊ฐ๋Ÿ‰์„ ์œ„ํ•œ ๊ณ ๋‹จ๋ฐฑ์งˆยท์ €ํƒ„์ˆ˜ํ™”๋ฌผ ์‹์‚ฌ์˜ ์•ˆ์ „์„ฑ๊ณผ ํšจ๊ณผ๋ฅผ ์•Œ์•„๋ณธ ์—ฐ๊ตฌ์—์„œ ๊ณ ๋‹จ๋ฐฑ์งˆยท์ €ํƒ„์ˆ˜ํ™”๋ฌผ ์‹์‚ฌ์˜ ํƒ„์ˆ˜ํ™”๋ฌผ, ๋‹จ๋ฐฑ์งˆ, ์ง€๋ฐฉ์˜ ์กฐ์„ฑ์€ ํ‰๊ท  11%, 32%,

57%, ์ €์ง€๋ฐฉ ์‹์‚ฌ๋Š” ํ‰๊ท  51%, 21%, 29%์ด์—ˆ๊ณ , ์ด๋•Œ ์ œ๊ณตํ•œ ํƒ„์ˆ˜ํ™”๋ฌผ์˜ ์–‘์€ ๊ฐ๊ฐ 32 g, 188

g์ด์—ˆ๋‹ค. ๋˜ํ•œ ์ด์™€ ์œ ์‚ฌํ•œ ์ €ํƒ„์ˆ˜ํ™”๋ฌผ ๋˜๋Š” ๊ณ ํƒ„์ˆ˜ํ™”๋ฌผ ์‹์‚ฌ์˜ ์ฒด์ค‘ ๊ฐ๋Ÿ‰์˜ ์œ ์‚ฌ์„ฑ์„ ๋น„๊ตํ•œ ์—ฐ๊ตฌ์—์„œ๋Š” ์ €ํƒ„์ˆ˜ํ™”๋ฌผ ์‹์‚ฌ์˜ ํƒ„์ˆ˜ํ™”๋ฌผ, ๋‹จ๋ฐฑ์งˆ, ์ง€๋ฐฉ ์กฐ์„ฑ์€ ํ‰๊ท  15%, 23%, 53% ๊ณ ํƒ„

472https://doi.org/10.4163/jnh.2020.53.5.464

๋‹น๋ถ€ํ•˜๋Ÿ‰์— ๋”ฐ๋ฅธ ์ฒด์ค‘ ๊ฐ๋Ÿ‰ ํšจ๊ณผ ์—ฐ๊ตฌ

https://e-jnh.org

์ˆ˜ํ™”๋ฌผ ์‹์‚ฌ๋Š” ํ‰๊ท  45%, 26%, 29%์ด์—ˆ๊ณ , ํƒ„์ˆ˜ํ™”๋ฌผ ์–‘์€ ๊ฐ๊ฐ 37 g๊ณผ 115 g์ด์—ˆ๋‹ค [21,22]. ์ด๋“ค ์—ฐ๊ตฌ์—์„œ๋Š” ์ฒด์ค‘๋ณ€ํ™”๋Š” ์žˆ์—ˆ์œผ๋‚˜ ์ธ์ฒด์— ๋ฌด๋ฆฌ๊ฐ€ ์—†๋Š” ์ตœ์†Œํ•œ์˜ ์–‘์ธ 50โ€“100 g ์ด์ƒ์˜ ํƒ„์ˆ˜ํ™”๋ฌผ์„ ๊ณต๊ธ‰ํ•œ ๊ฒƒ์ด ์•„๋‹ˆ๋ผ ์žฅ๊ธฐ์ ์œผ๋กœ ์ง€์†ํ•˜๊ธฐ ์–ด๋ ค์šด ์‹์‚ฌ ์กฐ์„ฑ์ด๋ผ๊ณ  ์ƒ๊ฐ๋œ๋‹ค. ๊ทธ๋Ÿฌ๋‚˜ ๋ณธ ์—ฐ๊ตฌ๋Š” ๋‹น๋ถ€ํ•˜๋Ÿ‰์„ ๊ณ ๋ คํ•˜์˜€์„ ๋ฟ๋งŒ ์•„๋‹ˆ๋ผ ๋‹จ๋ฐฑ์งˆ์„ ์ ˆ์•ฝํ•˜๊ณ  ์ผ€ํ†ค์ฆ ๋ฐ ์‹ฌํ•œ ์ˆ˜๋ถ„์†์‹ค์„ ์˜ˆ๋ฐฉํ•  ์ˆ˜ ์žˆ๋„๋ก ํ•˜๋ฃจ 100 g ์ด์ƒ์˜ ๋‹น์งˆ์„ ๊ณต๊ธ‰ํ•˜๋Š” ์ค‘ํƒ„์ˆ˜ํ™”๋ฌผ ์‹์‚ฌ๋กœ ์ œ๊ณตํ–ˆ๋‹ค๋Š” ๊ฒƒ์ด ์žฅ์ ์œผ๋กœ ์ œ์‹œ๋  ์ˆ˜ ์žˆ๋‹ค [23].

์ €ํƒ„์ˆ˜ํ™”๋ฌผยท๊ณ ์ง€๋ฐฉ ์‹์‚ฌ์—์„œ ์ค‘์„ฑ์ง€๋ฐฉ์ด ๊ฐ์†Œ๋˜๊ณ  HDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค์ด ์ฆ๊ฐ€๋˜๋Š” ๊ฒƒ์œผ๋กœ ๋‚˜ํƒ€๋‚ฌ๊ณ , ๊ณ ํƒ„์ˆ˜ํ™”๋ฌผยท์ €์ง€๋ฐฉ ์‹์‚ฌ์—์„œ๋Š” ์ด์ฝœ๋ ˆ์Šคํ…Œ๋กค๊ณผ LDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค์˜ ๊ฐ์†Œ๊ฐ€ ํฐ ๊ฒƒ์œผ๋กœ

๋ณด๊ณ ๋˜๊ณ  ์žˆ์œผ๋‚˜ ๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ์œ ์‚ฌํ•œ ๊ฒฐ๊ณผ๊ฐ€ ๋‚˜ํƒ€๋‚˜์ง€ ์•Š์•˜๋‹ค [19,20,24]. ๋˜ํ•œ ์—ฌ๋Ÿฌ ์—ฐ๊ตฌ์—์„œ๋Š” ์ €ํƒ„์ˆ˜ํ™”๋ฌผ ์‹์‚ฌ๋ฅผ ์„ญ์ทจ ํ•œ ๊ฒฐ๊ณผ ์ธ์Š๋ฆฐ ๋†๋„๊ฐ€ ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œ๋˜์—ˆ๊ณ , ์ธ์Š๋ฆฐ ๋Œ€์‚ฌ ๋ณ€ํ™”๊ฐ€ ๋” ํฐ ๊ฒƒ์œผ๋กœ ๋ณด๊ณ ๋˜์—ˆ์œผ๋‚˜ [18,19,21] ๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ๋‘ ์ข…๋ฅ˜์˜ ์‹คํ—˜ ์‹์‚ฌ ์„ญ์ทจ ์ „๊ณผ ํ›„ ๋น„๊ต์—์„œ ๋ชจ๋‘ ์ธ์Š๋ฆฐ ๋†๋„์—์„œ๋Š” ์œ ์˜์ ์ธ ์ฐจ์ด๊ฐ€ ์—†์—ˆ์ง€๋งŒ ์ธ์Š๋ฆฐ ๋ถ„๋น„์™€ ์ €ํ•ญ์ƒํƒœ๋ฅผ ์ถ”์ •ํ• 

์ˆ˜ ์žˆ๋Š” C-peptide์™€ C-peptide ์ €ํ•ญ ์ง€์ˆ˜๊ฐ€ ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œ๋˜์—ˆ๋‹ค. ์ถ”ํ›„ ๋‹น๋ถ€ํ•˜๋Ÿ‰ ์‹์‚ฌ์— ๋”ฐ๋ฅธ ์ง€์งˆ ์„ฑ๋ถ„ ๋ณ€ํ™” ๋ฐ ์ธ์Š๋ฆฐ, C-peptide์™€ ๊ด€๋ จ๋œ ์—ฐ๊ตฌ๊ฐ€ ๋” ํ•„์š”ํ•จ์„ ์‹œ์‚ฌํ•œ๋‹ค [25].

๋ชจ๋“  ๋Œ€์ƒ์ž (n = 21)์—์„œ ์ „์ฒด ์‹คํ—˜ ๊ธฐ๊ฐ„ ์ „, ํ›„ ์ฐจ์ด๋ฅผ ๋น„๊ตํ•œ ๊ฒฐ๊ณผ ์ฒด์ค‘, ์ฒด์ง€๋ฐฉ๋Ÿ‰, ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜, ์ฒด์ง€๋ฐฉ๋ฅ , ํ˜ˆ์•• (์ˆ˜์ถ•๊ธฐ, ์ด์™„๊ธฐ), ์ด์ฝœ๋ ˆ์Šคํ…Œ๋กค, HDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, LDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, ๊ณต๋ณตํ˜ˆ๋‹น, ๋‹นํ™”ํ˜ˆ์ƒ‰์†Œ, C-peptide, C-peptide HOMA ์ง€์ˆ˜๊ฐ€ ๋ชจ๋‘ ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œํ•œ ๊ฒƒ์€ ๋‹น๋ถ€ํ•˜๋Ÿ‰์— ๊ด€๊ณ„์—†์ด ์ œํ•œ๋œ ์—ด๋Ÿ‰์„ ์„ญ์ทจํ•œ 4์ฃผ ๋™์•ˆ ์ฒด์ค‘ ๊ฐ์†Œ์™€ ํ•จ๊ป˜ ์ฒด์„ฑ๋ถ„ ๋ฐ ํ˜ˆ์ค‘ ์ง€์งˆ ๋†๋„

๊ฐœ์„ ๊ณผ ์œ ๊ด€ํ•œ ๊ฒƒ์œผ๋กœ ์ถ”์ •๋œ๋‹ค.

Foster ๋“ฑ [20]์˜ ์—ฐ๊ตฌ์—์„œ ์ฒด์ค‘ ๊ฐ๋Ÿ‰ ์‹คํ—˜ ํ›„ 6๊ฐœ์›” ๋™์•ˆ ์ฒด์ค‘์ด ๊ฐ์†Œํ•˜๋‹ค๊ฐ€ ๊ทธ ์ดํ›„ ๋‹ค์‹œ ์ฆ๊ฐ€ํ•˜๋Š” ๊ฒฝํ–ฅ์„ ๋ณด์˜€๊ณ , Tay ๋“ฑ [24]์˜ ์—ฐ๊ตฌ์—์„œ๋Š” ์‹์‚ฌ ์„ญ์ทจ 24์ฃผ ํ›„์— ํ˜ˆ์••์ด ๋ชจ๋‘ ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œ๋˜์—ˆ๊ณ  ์นผ๋กœ๋ฆฌ๋ฅผ ์ œํ•œํ•œ ์ƒํƒœ์—์„œ ์ €ํƒ„์ˆ˜ํ™”๋ฌผยท๊ณ ์ง€๋ฐฉ ์‹์‚ฌ๋Š” ์ผ์‹œ์ ์ธ ์ฒด์ค‘ ๊ฐ์†Œ๊ฐ€

์˜ค๋žœ ๊ธฐ๊ฐ„ ์ง€์†๋˜์ง€ ์•Š๋Š”๋‹ค๊ณ  ๋ณด๊ณ ๋˜์—ˆ์œผ๋‚˜ ๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ๊ฑด๊ฐ•ํ•œ ๋น„๋งŒ์ธ ๋˜๋Š” ๊ณผ์ฒด์ค‘์—๊ฒŒ์„œ low GL ์‹์‚ฌ, high GL ์‹์‚ฌ ์„ญ์ทจ ๊ธฐ๊ฐ„์ด ๊ฐ๊ฐ 2์ฃผ๋กœ ์งง์•„ ์ฒด์ค‘ ๋ณ€ํ™”์˜ ์ง€์†์„ฑ์„ ๊ด€์ฐฐํ•  ์ˆ˜

์—†์—ˆ๋‹ค. ์ฒด์ค‘, ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜, ์ฒด์ง€๋ฐฉ, ํ˜ˆ์••, ์ƒํ™œ์Šต๊ด€๋ณ‘ ๊ด€๋ จ ์š”์†Œ ๋“ฑ์˜ ๋ณ€ํ™” ์ถ”์ด๋ฅผ ์•Œ๊ธฐ ์œ„ํ•ด์„œ๋Š” ๋” ์˜ค๋žœ ๊ธฐ๊ฐ„์˜ ์‹คํ—˜์ด ์ง„ํ–‰๋˜์–ด์•ผ ํ•  ๊ฒƒ์œผ๋กœ ์‚ฌ๋ฃŒ๋œ๋‹ค. ๋ณธ ์—ฐ๊ตฌ๋Š” ๋Œ€์ƒ์ž์˜ ์ƒํ™œ์Šต๊ด€๋ณ‘ ๊ด€๋ จ ์š”์†Œ๋ฅผ ๊ณ ๋ คํ•˜์ง€ ์•Š๊ณ  ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜์™€ ์ฒด์ง€๋ฐฉ๋ฅ ์„ ๊ธฐ์ค€์œผ๋กœ๋งŒ ์„ ๋ฐœํ–ˆ๊ธฐ ๋•Œ๋ฌธ์— ๋Œ€์ƒ์ž๋ฅผ ์ผ๋ฐ˜ํ™”ํ•˜๊ธฐ ์–ด๋ ต๋‹ค๋Š” ์ œํ•œ์ ์ด ์žˆ๋‹ค. ๋˜ํ•œ ๋Œ€์‚ฌ์ฆํ›„๊ตฐ ์œ„ํ—˜์˜ ๋…ธ์ถœ ๊ธฐ๊ฐ„์ด ์ƒ๋Œ€์ ์œผ๋กœ

์งง์€ ๊ฑด๊ฐ•ํ•œ 20๋Œ€ ์„ฑ์ธ๋‚จ๋…€๋ฅผ ๋Œ€์ƒ์œผ๋กœ ํ•˜์˜€๊ธฐ ๋•Œ๋ฌธ์— ๋Œ€์‚ฌ์ฆํ›„๊ตฐ ์œ„ํ—˜์ด ๋†’์€ ๋Œ€์ƒ์ž๋“ค์—

๋Œ€ํ•œ ์—ฐ๊ตฌ๊ฐ€ ํ•„์š”ํ•˜๋‹ค. ๋‹น๋ถ€ํ•˜๋Ÿ‰์ด ์ ์€ ์‹์‚ฌ์˜ ์ฒด์ค‘ ๊ฐ๋Ÿ‰ ํšจ๊ณผ๋ฅผ ์ผ๋ฐ˜ํ™”ํ•˜๊ธฐ ์œ„ํ•ด ๋Œ€์‚ฌ์ฆํ›„๊ตฐ ๊ด€๋ จ ์œ„ํ—˜๋„๊ฐ€ ๋†’์€ ๋Œ€์ƒ์ž๋“ค๋กœ ํ™•๋Œ€ํ•˜์—ฌ ์ด๋ฅผ ๋Œ€์ƒ์œผ๋กœ ์ถ”๊ฐ€ ์—ฐ๊ตฌ๋ฅผ ์ง„ํ–‰ํ•˜๊ณ ์ž ํ•œ๋‹ค.

์š”์•ฝ

๋ณธ ์—ฐ๊ตฌ์—์„œ๋Š” ํ•œ๊ตญ์ธ์ด ํ‰์†Œ ์„ญ์ทจํ•˜๋Š” ์ผ๋ฐ˜์‹์‚ฌ์™€ ์œ ์‚ฌํ•œ ์ˆ˜์ค€์˜ ๋‹น๋ถ€ํ•˜๋Ÿ‰์„ ๊ฐ€์ง„ high GL

์‹์‚ฌ์™€ ๋‹น๋ถ€ํ•˜๋Ÿ‰์ด ๋‚ฎ๊ฒŒ ์„ค๊ณ„๋œ low GL ์‹์‚ฌ๋ฅผ ์„ญ์ทจํ•œ ํ›„ ์ฒด์ค‘, ์ฒด์ง€๋ฐฉ, ํ˜ˆ์•• ๋ฐ ํ˜ˆ์•ก ๋‚ด ์ƒํ™œ์Šต๊ด€๋ณ‘ ์œ„ํ—˜ ์ง€ํ‘œ ๋“ฑ์˜ ๋ณ€ํ™”๋ฅผ ๋ถ„์„ ๋ฐ ๋น„๊ตํ•˜์˜€๋‹ค. 20๋Œ€ ์„ฑ์ธ๋‚จ๋…€๋ฅผ ๋Œ€์ƒ์œผ๋กœ ์ฒด์ค‘ ๊ฐ๋Ÿ‰์„

์œ„ํ•ด wash-out ๊ธฐ๊ฐ„์ธ ์ค‘๊ฐ„ 2์ฃผ๋ฅผ ์ œ์™ธํ•˜๊ณ  ๊ฐœ์ธ ํ•„์š” ์—ด๋Ÿ‰์˜ 30%๋ฅผ ์ค„์ธ low GL ์‹์‚ฌ์™€ high

473https://doi.org/10.4163/jnh.2020.53.5.464

๋‹น๋ถ€ํ•˜๋Ÿ‰์— ๋”ฐ๋ฅธ ์ฒด์ค‘ ๊ฐ๋Ÿ‰ ํšจ๊ณผ ์—ฐ๊ตฌ

https://e-jnh.org

GL ์‹์‚ฌ๋ฅผ ๊ฐ 2์ฃผ๊ฐ„ ์ œ๊ณตํ•˜์˜€๋‹ค. Low GL ์‹์‚ฌ์™€ high GL ์‹์‚ฌ์˜ ํšจ๊ณผ๋ฅผ ๋น„๊ตํ•œ ๊ฒฐ๊ณผ low GL

์‹์‚ฌ๊ฐ€ high GL ์‹์‚ฌ์— ๋น„ํ•ด ์ฒด์ค‘ (p < 0.001), ์ฒด์ง€๋ฐฉ๋Ÿ‰ (p = 0.024), ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜ (p < 0.001)์—์„œ ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œ๋Ÿ‰์ด ๋” ์ปธ๋‹ค. ํ•˜์ง€๋งŒ ํ˜ˆ์••, ํ˜ˆ์•ก ๋‚ด ๋น„๋งŒ ์งˆํ™˜ ์œ„ํ—˜ ์ง€ํ‘œ์—์„œ๋Š” ์œ ์˜ํ•œ ์ฐจ์ด๊ฐ€ ์—†์—ˆ๋‹ค. Low GL ์‹์‚ฌ์˜ ์ „ยทํ›„๋ฅผ ๋น„๊ตํ•œ ๊ฒฐ๊ณผ ์ฒด์ค‘, ์ฒด์ง€๋ฐฉ๋Ÿ‰, ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜, ์ฒด์ง€๋ฐฉ๋ฅ , ์ด์™„๊ธฐ ํ˜ˆ์••, ์ค‘์„ฑ์ง€๋ฐฉ, ์ด์ฝœ๋ ˆ์Šคํ…Œ๋กค, HDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, LDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, ๊ณต๋ณตํ˜ˆ๋‹น, C-peptide

HOMA ์ง€์ˆ˜๊ฐ€, high GL ์‹์‚ฌ์—์„œ๋Š” ์ฒด์ค‘, ์ฒด์ง€๋ฐฉ๋Ÿ‰, ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜, ์ด์ฝœ๋ ˆ์Šคํ…Œ๋กค, HDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, ๊ณต๋ณตํ˜ˆ๋‹น, C-peptide, C-peptide HOMA ์ง€์ˆ˜์—์„œ ๊ฐ ์‹์‚ฌ ์ „๋ณด๋‹ค ํ›„์— ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œ๋˜์—ˆ๋‹ค. ๋˜ํ•œ ์‹คํ—˜ ์‹์‚ฌ ์„ญ์ทจ ์ „๊ณผ ์„ญ์ทจ ํ›„๋ฅผ ๋น„๊ตํ•œ ๊ฒฐ๊ณผ ์ฒด์ค‘, ์ฒด์ง€๋ฐฉ๋Ÿ‰, ์ฒด์งˆ๋Ÿ‰์ง€์ˆ˜, ์ฒด์ง€๋ฐฉ๋ฅ , ํ˜ˆ์•• (์ˆ˜์ถ•๊ธฐ, ์ด์™„๊ธฐ), ์ด์ฝœ๋ ˆ์Šคํ…Œ๋กค, HDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, LDL-์ฝœ๋ ˆ์Šคํ…Œ๋กค, ๊ณต๋ณตํ˜ˆ๋‹น, ๋‹นํ™”ํ˜ˆ์ƒ‰์†Œ, C-peptide, C-peptide HOMA ์ง€์ˆ˜๊ฐ€ ๋ชจ๋‘ ์œ ์˜์ ์œผ๋กœ ๊ฐ์†Œ๋˜์—ˆ๋‹ค. ๋ณธ ์—ฐ๊ตฌ ๊ฒฐ๊ณผ ์ฒด์ค‘

๊ฐ๋Ÿ‰ ๋ฐ ์ƒํ™œ์Šต๊ด€๋ณ‘ ์œ„ํ—˜์„ ์ค„์ด๊ธฐ ์œ„ํ•ด์„œ๋Š” ๋‹จ์ˆœํžˆ ์„ญ์ทจ ์—ด๋Ÿ‰์„ ๋‚ฎ์ถ”๊ธฐ๋ณด๋‹ค๋Š” ์—ด๋Ÿ‰๊ณผ ํ•จ๊ป˜

๋‹น๋ถ€ํ•˜๋Ÿ‰์„ ๊ณ ๋ คํ•˜์—ฌ ์„ญ์ทจํ•˜๋Š” ๊ฒƒ์ด ์ฒด์ค‘์„ ๊ฐ์†Œ์‹œํ‚ค๋Š” ๋ฐ์— ๋” ํšจ๊ณผ์ ์ผ ๊ฒƒ์œผ๋กœ ์‚ฌ๋ฃŒ๋œ๋‹ค.

REFERENCES 1. Ma Y, Olendzki B, Chiriboga D, Hebert JR, Li Y, Li W, et al. Association between dietary carbohydrates

and body weight. Am J Epidemiol 2005; 161(4): 359-367. PUBMED | CROSSREF

2. Youn S, Woo HD, Cho YA, Shin A, Chang N, Kim J. Association between dietary carbohydrate, glycemic index, glycemic load, and the prevalence of obesity in Korean men and women. Nutr Res 2012; 32(3): 153-159. PUBMED | CROSSREF

3. Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea health statistics 2014: Korea National Health and Nutrition Examination Survey (KNHANES VI-2). Cheongju: Korea Centers for Disease Control and Prevention; 2015.

4. Song S, Choi H, Lee S, Park JM, Kim BR, Paik HY, et al. Establishing a table of glycemic index values for common Korean foods and an evaluation of the dietary glycemic index among the Korean adult population. Korean J Nutr 2012; 45(1): 80-93. CROSSREF

5. Barclay AW, Petocz P, McMillan-Price J, Flood VM, Prvan T, Mitchell P, et al. Glycemic index, glycemic load, and chronic disease risk--a meta-analysis of observational studies. Am J Clin Nutr 2008; 87(3): 627-637. PUBMED | CROSSREF

6. Jenkins DJ, Wolever TM, Jenkins AL. Starchy foods and glycemic index. Diabetes Care 1988; 11(2): 149-159. PUBMED | CROSSREF

7. Riccardi G, Rivellese AA, Giacco R. Role of glycemic index and glycemic load in the healthy state, in prediabetes, and in diabetes. Am J Clin Nutr 2008; 87(1): 269S-274S. PUBMED | CROSSREF

8. Denova-Gutiรฉrrez E, Huitrรณn-Bravo G, Talavera JO, Castaรฑรณn S, Gallegos-Carrillo K, Flores Y, et al. Dietary glycemic index, dietary glycemic load, blood lipids, and coronary heart disease. J Nutr Metab 2010; 2010: 170680. PUBMED | CROSSREF

9. Du H, van der A DL, van Bakel MM, van der Kallen CJ, Blaak EE, van Greevenbroek MM, et al. Glycemic index and glycemic load in relation to food and nutrient intake and metabolic risk factors in a Dutch population. Am J Clin Nutr 2008; 87(3): 655-661. PUBMED | CROSSREF

10. Lau C, Toft U, Tetens I, Richelsen B, Jรธrgensen T, Borch-Johnsen K, et al. Association between dietary glycemic index, glycemic load, and body mass index in the Inter99 study: is underreporting a problem? Am J Clin Nutr 2006; 84(3): 641-645. PUBMED | CROSSREF

11. Du H, Van der A DL, Feskens EJ. Dietary glycaemic index: a review of the physiological mechanisms and observed health impacts. Acta Cardiol 2006; 61(4): 383-397. PUBMED | CROSSREF

12. Chai HJ, Hong H, Kim HS, Lee JS, Yu CH. Relationship between food intakes, glycemic index, glycemic load, and body weight among high school boys in Seoul. Korean J Nutr 2008; 41(7): 645-657.

474https://doi.org/10.4163/jnh.2020.53.5.464

๋‹น๋ถ€ํ•˜๋Ÿ‰์— ๋”ฐ๋ฅธ ์ฒด์ค‘ ๊ฐ๋Ÿ‰ ํšจ๊ณผ ์—ฐ๊ตฌ

https://e-jnh.org

13. The Korean Dietetic Association. Manual of medical nutrition therapy, 3rd edition. Seoul: The Korean Dietetic Association; 2008.

14. Park MH, Chung SJ, Shim JE, Jang SH, Nam KS. Effects of macronutrients in mixed meals on postprandial glycemic response. J Nutr Health 2018; 51(1): 31-39. CROSSREF

15. Wallace TM, Levy JC, Matthews DR. Use and abuse of HOMA modeling. Diabetes Care 2004; 27(6): 1487-1495. PUBMED | CROSSREF

16. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21(12): 2191-2192. PUBMED | CROSSREF

17. Song S, Paik HY, Song Y. The relationship between intake of nutrients and food groups and insulin resistance in Korean adults: using the fourth Korea National Health and Nutrition Examination Survey (KNHANES IV, 2007โ€“2009). Korean J Nutr 2013; 46(1): 61-71. CROSSREF

18. Hall KD, Bemis T, Brychta R, Chen KY, Courville A, Crayner EJ, et al. Calorie for calorie, dietary fat restriction results in more body fat loss than carbohydrate restriction in people with obesity. Cell Metab 2015; 22(3): 427-436. PUBMED | CROSSREF

19. Noakes M, Foster PR, Keogh JB, James AP, Mamo JC, Clifton PM. Comparison of isocaloric very low carbohydrate/high saturated fat and high carbohydrate/low saturated fat diets on body composition and cardiovascular risk. Nutr Metab (Lond) 2006; 3(1): 7. PUBMED | CROSSREF

20. Foster GD, Wyatt HR, Hill JO, McGuckin BG, Brill C, Mohammed BS, et al. A randomized trial of a low-carbohydrate diet for obesity. N Engl J Med 2003; 348(21): 2082-2090. PUBMED | CROSSREF

21. Golay A, Allaz AF, Morel Y, de Tonnac N, Tankova S, Reaven G. Similar weight loss with low- or high-carbohydrate diets. Am J Clin Nutr 1996; 63(2): 174-178. PUBMED | CROSSREF

22. Krebs NF, Gao D, Gralla J, Collins JS, Johnson SL. Efficacy and safety of a high protein, low carbohydrate diet for weight loss in severely obese adolescents. J Pediatr 2010; 157(2): 252-258. PUBMED | CROSSREF

23. Lee MS, Lee SY, Kim HA, Jung SJ, Kim WK, Kim HJ. Climical nutrition. Goyang: Powerbook; 2010.

24. Tay J, Brinkworth GD, Noakes M, Keogh J, Clifton PM. Metabolic effects of weight loss on a very-low-carbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjects. J Am Coll Cardiol 2008; 51(1): 59-67. PUBMED | CROSSREF

25. Salway JG. Medical biochemistry at a glance, 3rd edition. Chichester: Wiley-Blackwell; 2012.

475https://doi.org/10.4163/jnh.2020.53.5.464

๋‹น๋ถ€ํ•˜๋Ÿ‰์— ๋”ฐ๋ฅธ ์ฒด์ค‘ ๊ฐ๋Ÿ‰ ํšจ๊ณผ ์—ฐ๊ตฌ

https://e-jnh.org